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Abstract 
 
Due to the lack of exercise testing devices that can be employed in stroke patients with 
severe disability, the aim of this PhD research was to investigate the clinical feasibility of 
using a robotics-assisted tilt table (RATT) as a method for cardiopulmonary exercise testing 
(CPET) and exercise training in stroke patients. For this purpose, the RATT was augmented 
with force sensors, a visual feedback system and a work rate calculation algorithm. As the 
RATT had not been used previously for CPET, the first phase of this project focused on a 
feasibility study in 11 healthy able-bodied subjects. The results demonstrated substantial 
cardiopulmonary responses, no complications were found, and the method was deemed 
feasible. The second phase was to analyse validity and test-retest reliability of the primary 
CPET parameters obtained from the RATT in 18 healthy able-bodied subjects and to compare 
the outcomes to those obtained from standard exercise testing devices (a cycle ergometer 
and a treadmill). The results demonstrated that peak oxygen uptake (V'O2peak) and oxygen 
uptake at the submaximal exercise thresholds on the RATT were  ̴20% lower than for the 
cycle ergometer and  3̴0% lower than on the treadmill. A very high correlation was found 
between the RATT vs the cycle ergometer V'O2peak and the RATT vs the treadmill V'O2peak. 
Test-retest reliability of CPET parameters obtained from the RATT were similarly high to 
those for standard exercise testing devices. These findings suggested that the RATT is a valid 
and reliable device for CPET and that it has potential to be used in severely impaired 
patients. Thus, the third phase was to investigate using the RATT for CPET and exercise 
training in 8 severely disabled stroke patients. The method was technically implementable, 
well tolerated by the patients, and substantial cardiopulmonary responses were observed. 
Additionally, all patients could exercise at the recommended training intensity for 10 min 
bouts. Finally, an investigation of test-retest reliability and four-week changes in 
cardiopulmonary fitness was carried out in 17 stroke patients with various degrees of 
disability. Good to excellent test-retest reliability and repeatability were found for the main 
CPET variables. There was no significant difference in most CPET parameters over four 
weeks. In conclusion, based on the demonstrated validity, reliability and repeatability, the 
RATT was found to be a feasible and appropriate alternative exercise testing and training 
device for patients who have limitations for use of standard devices.  
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1. Introduction 
 
1.1 Stroke 
Stroke is characterized as a neurological deficit attributed to an acute focal injury of the 
central nervous system (CNS) by a vascular cause, including cerebral infarction, intracerebral 
haemorrhage (ICH), and subarachnoid haemorrhage (SAH) (Sacco et al., 2013). Stroke is a 
major cause of death and disability (Sacco et al., 2013). Annually, 15 million people suffer a 
stroke worldwide; one-third die and one-third are permanently disabled (Mackay and 
Mensah, 2004). In Europe, the incidence of stroke ranges from 101.1 to 239.3 per 100,000 in 
men and 63.0 to 158.7 per 100,000 in women (Heuschmann et al., 2009). The incidence is 
projected to increase as a result of a higher proportion of older people in the population in 
the future (Truelsen et al., 2006).  
 
Most stroke insults are not fatal but affect physical and psychological function (Singh et al., 
2000;Lai et al., 2002;Jonsson et al., 2005). The physical impairments are related to the area 
of brain damage, which can involve motor and sensory impairments, cognitive impairments, 
communication or swallowing (Brott et al., 1989;Patel et al., 2002). Stroke imposes a 
substantial impact on the individual, family and society (Scholte op Reimer et al., 
1998;Hickenbottom et al., 2002). The burden of stroke is high especially in people aged 80 
years or over, which contributes to about one-third of health care utilization (Marini et al., 
2004). 
 
1.2 Cardiopulmonary fitness after stroke 
Cardiopulmonary fitness is related to the ability to perform large muscle, dynamic, moderate 
to vigorous intensity exercise for prolonged periods of time (Pescatello et al., 2014). Maximal 
or peak oxygen uptake (V'O2max or V'O2peak), which reflect the integrative cardiopulmonary 
response to transport oxygen to muscle and the ability of the muscle cells to utilize it, is the 
most often considered criterion for cardiopulmonary fitness (McArdle et al., 
1996;Wasserman et al., 1999;Pescatello et al., 2014). Patients after stroke have severely 
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reduced cardiopulmonary fitness – their peak oxygen uptake (V'O2peak) is in the range of 8-22 
mL/kg/min which is approximately 26-87% of their age and sex-matched peers (Smith et al., 
2012).  
Cardiopulmonary fitness predicts the risk for cardiovascular disease, guides the prognosis for 
functional recovery, and is associated with the degree of independence in stroke patients 
(Smith et al., 2012;Kim et al., 2014). The low V'O2peak is associated with an increased 
incidence of cardiovascular disease and recurrent stroke (Smith et al., 2012). Additionally, it 
was reported that baseline V'O2peak negatively correlated with changes in V'O2peak after 
aerobic exercise training: individuals with the most compromised fitness level were found to 
gain the greatest benefit from an exercise intervention (Tang et al., 2013b). 
 
1.3 Cardiopulmonary exercise testing (CPET) in stroke patients  
In 2014, the American Heart Association Stroke Council recommended that individuals after 
stroke undergo cardiopulmonary exercise testing (CPET) as part of a medical evaluation 
before beginning an exercise programme (Billinger et al., 2014). The results obtained from 
CPET can be used to assess the patient’s aerobic capacity, to prescribe the optimal exercise 
intensity for training and to follow up after exercise intervention (Marzolini et al., 
2012;Billinger et al., 2014). The implementation of CPET in an exercise programme correlates 
well with the aims of stroke rehabilitation which are to decrease the rates of recurrent 
stroke and cardiovascular events, to prevent complications of prolonged inactivity and to 
increase cardiopulmonary fitness (Gordon et al., 2004). 
A systematic review examining the safety of CPET in stroke patients found only 11 adverse 
events from 876 CPETs (1.26%) (van de Port et al., 2015). Cardiovascular adverse events 
associated with CPET were reported in individual studies to be in the range of 0 to 11% (Kelly 
et al., 2003;Tang et al., 2006;Chen et al., 2010;Marzolini et al., 2012;Billinger et al., 2014). 
These included abnormal blood pressure (hypertensive response), ST segment depression, 
complex ventricular premature beats or ventricular tachycardia (Tang et al., 2006;Marzolini 
et al., 2012). 
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1.4 Exercise training in stroke patients 
Exercise improves cardiopulmonary fitness, which has a positive effect on functional capacity 
in patients’ daily activities (Macko et al., 2001). Short term exercise was shown to improve 
cardiopulmonary fitness and walking endurance in patients after stroke (Duncan et al., 
2003;Eich et al., 2004;Tang et al., 2009b). Moreover, exercise plays a role as a lifestyle 
intervention to prevent recurrent stroke and cardiac disease (Goldstein et al., 2006). It was 
found that the five main strategies, which are dietary modification, exercise, aspirin, a statin, 
and an antihypertensive agent, reduce the risk of recurrent vascular events by 80% in 
patients after stroke or transient ischemic attack (Hackam and Spence, 2007).  
 
Exercise after stroke is challenging due to barriers such as patient-related factors (e.g. 
depression, lack of interest, lack of motivation) and practical factors (lack of transportation, 
lack of availability of fitness resources) (Billinger et al., 2014). A survey of cardiac 
rehabilitation in 40 facilities showed that only 60% of the facilities enrolled stroke patients 
(Tang et al., 2009a). Nearly half of those which enrolled stroke patients accepted only 
patients as a secondary diagnosis or only with mild to moderate impairments (Tang et al., 
2009a). Some programmes accepted only mild and nondisabling cases: the most common 
reasons for rejecting participants were impaired walking ability (Tang et al., 2009a). The 
promotion of exercise in stroke survivors with moderate to severe disabilities would be 
challenging (Billinger et al., 2014). It was proposed that the barriers may be overcome by 
providing alternative exercise modalities which do not require trunk stability or independent 
limb control (Tang et al., 2009a).  
 
1.5 Current limitations of standard devices for CPET and exercise 
training in stroke patients 
Most CPET studies in stroke patients employed a cycle ergometer or a treadmill (Smith et al., 
2012). Unlike patients with heart or lung problems, stroke patients are a unique population 
with significant disabilities. Weakness, balance, coordination problems or insecurity i.e. a 
fear of falling, play an additional role in patients’ performance in CPET. It was found that 
stroke patients usually terminated CPET because of fatigue or problems related to 
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neuromuscular function instead of dyspnea or breathing effort (Tang et al., 2013a), which 
means that peripheral limitations play a larger role than cardiopulmonary limitations in test 
termination.  
The treadmill is considered the gold standard device for CPET in normal subjects. The peak 
cardiopulmonary performance values obtained from the treadmill are higher than those 
obtained from the cycle ergometer (Porszasz et al., 2003). Most people are more familiar 
with the movement of walking/running than cycling. However, exercise testing on a 
treadmill requires good walking ability, thus limiting its usability in moderately to severely 
disabled stroke patients. Additionally, walking ability and cardiopulmonary fitness in stroke 
are not necessary correlated (Outermans et al., 2015): although the ability to walk is related 
to cardiopulmonary fitness in abled-bodied subjects, it was found that in stroke patients the 
ability to walk is also related to balance, weakness or coordination problems (Pohl et al., 
2002;Pradon et al., 2013). It was shown that patients’ V'O2peak increased by approximately 
10% (V'O2peak improved from 20.6 to 22.5 mL/kg/min) with the use of an ankle-foot orthosis 
to stabilize the ankle during CPET on a treadmill, supporting the observation that patients 
stopped exercise because of neuromuscular limitations rather than cardiopulmonary 
limitations (Hyun et al., 2015). 
The cycle ergometer is the most common device used for CPET in stroke patients: less 
coordination is required and the risk of falling is lower than on the treadmill (Maeder et al., 
2005). However, studies that recruited stroke patients with mild to moderate disabilities 
reported that up to 3/4 of the patient exclusions were related to the set-up on the cycle 
ergometer (adductor spasticity, muscle weakness or reduced joint range of motion, and 
inability to perform the cyclical motion on the cycle ergometer) (Chu et al., 2004;Yates et al., 
2004). A semi-recumbent cycle ergometer provides a back rest and leg support to secure the 
lower extremities, thus enabling more patients to be tested (Carr and Jones, 2003;Tang et 
al., 2006;Tomczak et al., 2008;Billinger et al., 2014). 
Recent systematic reviews found that there is a lack of data on cardiopulmonary fitness in 
patients with severe stroke disability which may be because of the limitations of the 
treadmill and the cycle ergometer for testing in these patients (Stoller et al., 2012;Marsden 
et al., 2013). It is expected that the overall V'O2peak in stroke patients would have been lower 
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if the studies had tested severely disabled stroke patients (Smith et al., 2012;Marsden et al., 
2013). Exercise testing and training in severely disabled patients is understudied. 
 
1.6 Alternative devices for CPET in stroke patients 
Several alternative devices have been investigated to address the lack of appropriate testing 
devices in stroke patients. A total body recumbent stepper is a device generally used in 
fitness centres. It enables patients with balance or coordination problems to be tested and 
promotes both upper and lower extremity exercise (Billinger et al., 2008b). It is a validated 
device for CPET in both normal subjects and chronic stroke patients (Billinger et al., 
2008a;Billinger et al., 2008b). The V'O2peak achieved on the total body recumbent stepper is 
higher than the cycle ergometer, which may be due to the higher muscle mass used and 
lower fatigue during exercise (Billinger et al., 2008b). 
Robotics-assisted treadmill exercise was investigated for exercise testing and training. 
Although there is no validation study in normal subjects, it has been used in patients after 
spinal cord injury and stroke (Jack et al., 2010;Stoller et al., 2014a). Using this type of device 
for exercise provides advantages of repetitive task-orientated training for walking together 
with cardiopulmonary exercise at the same time (Stoller et al., 2015). However, there are 
some limitations of this device. Firstly, the difficulty and time needed for patients to be 
attached to the robotic orthoses. Secondly, during exercise the patients need to apply forces 
and there is a high coordinative demand to control the walking direction while the 
exoskeleton restricts the movement. Therefore, patients terminated the tests because of 
muscular or coordinative fatigue rather than cardiopulmonary limitations (Stoller et al., 
2014a). Finally, studies reported that 28.6 to 45.5% of stroke patients training on the 
robotics-assisted treadmill experienced skin-related problems when active participation was 
required (skin problems/pain from pressure or rubbing of straps or cuffs), although careful 
fitting of the straps and the addition of extra padding were provided (Kelly et al., 
2013;Stoller et al., 2015). This problem was usually found in weaker patients who had 
difficulty maintaining knee extension during the stance phase (Kelly et al., 2013). 
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Another potential device is an end-effector-based stair climbing and walking robot. 
However, to date, only a feasibility study of CPET using this device in healthy able-bodied 
subjects was done and it has not yet been tested for CPET in patient populations (Stoller et 
al., 2014b). 
 
1.7 Novel device for CPET and exercise training in stroke patients: a 
robotics-assisted tilt table 
A robotics-assisted tilt table (RATT) is a motorized tilt table with a body harness to support 
the body and two motor drives to provide cyclical movement of the legs (e.g. Erigo, Hocoma 
AG, Switzerland). Two thigh cuffs fix the legs and interface to the leg drives, and two foot 
plates support the feet. It is used clinically in severely disabled neurological patients for early 
mobilization and intensive sensorimotor stimulation. This is done by the RATT tilting the 
patient upright, and moving and providing cyclical loading for the patient’s lower limbs. 
During the therapy, the RATT can be tilted up from 0 to 80 degrees and the cyclic leg 
movement can be set to a stepping cadence between 8 and 80 steps/min. 
The RATT has potential for the implementation in CPET and exercise training in patients with 
disability. The reasons are as follows: 
1. The body harness provides adequate security for patients with balance or 
coordination problems or fear of falling. The total body support lessens the chance of 
exercised-related injuries.  
2. The thigh cuffs and foot plates secure the lower extremities, which enables patients 
with severe lower extremity weakness or spasticity to exercise. Additionally, the foot 
plate can be adjusted to deformity such as ankle equinus from gastrocnemius-soleus 
spasticity. 
3. It takes 5 to 10 minutes to fit the patient on the RATT. The patients can be 
transferred to the RATT both in lying and sitting positions. 
4. In case of emergency, the RATT can be tilted down and all the straps can be released 
immediately. Emergency medical care, if required, can be done on the RATT. 
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The RATT was augmented with force sensors and a visual feedback system so that severely 
disabled neurological patients can actively participate in exercise testing and training on the 
device (Bichsel et al., 2011). The visual feedback screen gives direct performance feedback 
during exercise and is a motivating factor. 
 
 
 
Figure 1. Robotics-assisted tilt table (RATT) with visual feedback system. The visual feedback 
screen shows the target work rate and the subject’s work rate. The subject’s work rate was 
calculated from the forces in the thigh cuffs and the angular velocities. 
 
We proposed that this device may be appropriate for cardiopulmonary exercise testing and 
training in patients who have severe neurological deficits, including severely-disabled stroke 
patients. However, there is a lack of basic knowledge and supportive evidence for the use of 
the RATT. This PhD project was carried out to address these open questions. 
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2. Empirical Contribution 
 
Due to the lack of exercise testing devices that can be employed in stroke patients with 
moderate to severe disability, the aim of the PhD project was to investigate the clinical 
feasibility of using the augmented RATT as a method for cardiopulmonary exercise testing 
and training in stroke patients.   
As the RATT had not been used previously for exercise testing and training, the study was 
planned using a stepwise approach beginning with a feasibility study in healthy able-bodied 
subjects. Then, comparative and test-retest reliability analyses for cardiopulmonary 
performance parameters obtained from the RATT and standard exercise devices (cycle and 
treadmill ergometers) were done. Following these investigations of feasibility, validity and 
reliability of this new method in healthy able-bodied subjects, a feasibility study of exercise 
testing and training in severely disabled stroke patients was done. Finally, an investigation of 
test-retest reliability and longitudinal changes in cardiopulmonary fitness was done in stroke 
patients with various degrees of disability. 
Thus, we defined 4 main objectives:  
1. To conduct a feasibility study using the RATT for cardiopulmonary exercise testing in 
healthy able-bodied subjects. 
2. To compare cardiopulmonary performance parameters and test-retest reliability 
achieved from the RATT, a cycle ergometer and a treadmill in healthy able-bodied 
subjects. 
3. To evaluate the clinical feasibility of the RATT for cardiopulmonary exercise testing 
and training in severely disabled, non-ambulatory stroke patients. 
4. To analyse test-retest reliability and to prospectively study changes in 
cardiopulmonary fitness over 4 weeks in stroke patients with various degrees of 
disability using the RATT. 
 
The original publications corresponding to each of these objectives, are presented in  
Chapter 3:  
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• Objective 1: the feasibility study using the RATT for cardiopulmonary exercise testing 
was done in 11 healthy able-bodied subjects (Chapter 3.1). 
• Objective 2: Chapter 3.2 presents a comparison of peak cardiopulmonary exercise 
performance parameters obtained from the RATT, a cycle ergometer and a treadmill 
using 18 healthy able-bodied subjects. Test-retest reliability of the peak 
cardiopulmonary performance parameters was also quantified. Further analysis to 
compare submaximal exercise parameters from the RATT, a cycle ergometer and a 
treadmill is reported in Chapter 3.3. 
• Objective 3: Chapter 3.4 presents the results of the feasibility study of 
cardiopulmonary exercise testing and training in 8 dependent-ambulatory stroke 
patients. 
• Objective 4: chapter 3.5 presents the result of test-retest reliability analysis and the 
prospective 4-week changes in cardiopulmonary fitness in 17 stroke patients. 
 
A general discussion and an overall outlook are presented in Chapter 4.  
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Abstract 
 
Background: Robotics-assisted tilt table technology was introduced for early 
rehabilitation of neurological patients. It provides cyclical stepping movement and 
physiological loading of the legs. The aim of the present study was to assess the 
feasibility of this type of device for peak cardiopulmonary performance testing using 
able-bodied subjects. 
 
Methods: A robotics-assisted tilt table was augmented with force sensors in the thigh 
cuffs and a work rate estimation algorithm. A custom visual feedback system was 
employed to guide the subjects' work rate and to provide real time feedback of actual 
work rate. Feasibility assessment focused on: (i) implementation (technical feasibility), 
and (ii) responsiveness (was there a measurable, high-level cardiopulmonary reaction?). 
For responsiveness testing, each subject carried out an incremental exercise test to the 
limit of functional capacity with a work rate increment of 5W/min in female subjects and 
8 W/min in males. 
 
Results: 11 able-bodied subjects were included (9 male, 2 female; age 29.6 ± 7.1 years: 
mean ± SD). Resting oxygen uptake (V O2) was 4.6 ± 0.7 mL/min/kg and VO2peak was 32.4 ± 
5.1 mL/min/kg; this mean VO2peak was 81.1% of the predicted peak value for cycle 
ergometry. Peak heart rate (HRpeak) was 177.5 ± 9.7 beats/min; all subjects reached at 
least 85% of their predicted HRpeak value. Respiratory exchange ratio (RER) at VO2peak 
was 1.02 ± 0.07. Peak work rate was 61.3 ± 15.1 W. All subjects reported a Borg CR10 value 
for exertion and leg fatigue of 7 or more. 
 
Conclusions: The robotics-assisted tilt table is deemed feasible for peak 
cardiopulmonary performance testing: the approach was found to be technically 
implementable and substantial cardiopulmonary responses were observed. Further 
testing in neurologically-impaired subjects is warranted. 
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1. Introduction 
 
Maximal oxygen uptake (VO2max) or peak oxygen uptake (VO2peak) is often used in 
evaluation of physical fitness (Buchfuhrer et al., 1983;Basset and Boulay, 2000). This value 
is of obvious clinical importance as it provides objective information on the functional 
status of the cardiovascular, pulmonary and musculoskeletal systems (Bassett and Howley, 
2000;Sagiv et al., 2007). It can also be used to guide exercise prescription and to predict 
cardiovascular survival (Koelling et al., 2004;O'Neill et al., 2005;Kodama et al., 2009). 
 
The most widely recommended and used devices for measuring maximal 
cardiopulmonary performance are the treadmill and the cycle ergometer (Myers et al., 
1991;Maffeis et al., 1994;Bader et al., 1999). However, both the treadmill and the cycle 
ergometer may have limitations when used in patients with neurological problems. Thus 
there is limited information about V O2peak in stroke patients and often the protocols 
have to be modified or additional support is needed (Macko et al., 1997;Yates et al., 
2004;Tang et al., 2006). Even with modifications or external support for the treadmill or 
cycle ergometer, severely compromised patients often have problems in performing the 
test. 
 
Robotics-assisted tilt table (RATT) technology with integrated leg drives for basic stepping 
functionality is clinically available for patients with neurological impairments. Initially 
introduced for early rehabilitation, it provides cyclical stepping movement and 
physiological loading in immobilized patients or patients on long bed rest. This technology 
provides stability and support in patients with neurological disorders such as stroke for 
whom weakness, balance and coordination problems would preclude cardiopulmonary 
performance testing using a conventional device. In our research to date, the functionality 
of this device has been extended by adding force sensors, work rate calculation and a 
visual feedback system to guide exercise intensity during cardiopulmonary testing and 
training (Bichsel et al., 2011). 
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We propose that this device may facilitate the estimation of VO2peak and other important 
cardiopulmonary performance parameters in patients who have neurological deficits. 
However, there is currently a lack of feasibility data to assess implementability and 
responsiveness of the augmented RATT device for cardiopulmonary performance testing 
even in the healthy population. Therefore, the aim of the present study was to assess the 
feasibility, i.e. implementation and responsiveness, of the augmented RATT device for peak 
cardiopulmonary performance testing using able-bodied subjects. 
 
2. Methods 
 
Ethics statement 
 
The study was reviewed and approved by the ethics committee of the Swiss Canton of Bern 
(Kantonale Ethikkommission (KEK) Bern). Written informed consent was obtained from all 
subjects prior to participation. 
 
Subjects 
 
Eleven subjects were recruited (Table 1) and all completed the tests. All subjects reported 
no neuromuscular, pulmonary, cardiovascular or musculoskeletal impairments that might 
have precluded maximal performance testing. 
 
Table 1. Subject data. Predicted HRpeak is 220 – age. Predicted VO2peak calculated 
according to Wasserman et al. (1999). 
Characteristic Value – mean (SD) 
Age [years] 29.6 (7.1) 
Male/Female [n] 9/2 
Height [cm] 173.6 (10.0) 
Body mass [kg] 69.2 (13.4) 
Body mass index [kg/m2] 22.8 (2.4) 
Predicted HRpeak [beats/min] 190 (7) 
Predicted VO2peak [L/min] 2.8 (0.6) 
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Robotics-assisted tilt table 
 
A robotics-assisted tilt table was employed (Erigo, Hocoma AG, Switzerland) which was 
augmented with force sensors in the thigh cuffs together with a work rate estimation 
algorithm (Figure 1). A custom visual feedback system was used to guide the subjects' 
work rate and to provide real time feedback of actual work rate (Figure 2). The step 
frequency was set as 80 steps/min and range of motion of the hip joints as 10-35 
degrees. 
 
 
 
Figure 1. Work rate estimation and visual feedback. The subject's work rate is estimated 
continuously from forces in the thigh cuffs and joint angular velocities. A target work rate 
profile is displayed with the estimated work rate and the subject must adapt volitional 
muscular work to maintain the target. Physiological variables are monitored continuously 
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Figure 2. The augmented robotics-assisted tilt table (RATT) system with force sensors under 
the thigh cuffs, visual feedback system and breath-by-breath cardiopulmonary monitoring 
system. 
 
Procedures 
Subjects were instructed to avoid strenuous activity within the 24 hours before testing and 
not to consume nicotine, caffeine or a large amount of food at least 3 hours prior to testing. 
 
Each subject performed 1 incremental exercise test on the augmented RATT. Prior to the 
incremental phase of the test, the protocol included a warm up and passive measurement 
(Figure 3). The subjects initially lay horizontal on the tilt table and were secured in 
accordance with the provisions of the support system. The thighs and the feet were fixed 
to the thigh cuffs and foot straps respectively. The test protocol was explained to the 
subject and the measurement and gas exchange monitoring systems were introduced. The 
subject was then tilted up to 70 degrees and the formal test protocol (Figure 3) 
commenced: there was a recorded rest phase of 3 minutes followed by a warm up phase of 
exercising at a work rate of 15 W for 5 minutes. Then subjects had 3 minutes of rest for 
recovery and 3 minutes for "passive," unloaded movement before the incremental exercise 
phase. During unloaded movement the device was active while the subject was instructed  
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to remain passive. For the incremental exercise phase, the work rate increment was  
5 W/min in females and 8 W/min in males. This phase was terminated volitionally by the 
subjects after they could no longer maintain the work rate target and had reached their 
functional limit. After the incremental exercise phase there was a passive phase for 3 
minutes for recovery. To maintain the target work rate, the subject was instructed to 
actively push upwards and downwards into the thigh cuffs in the direction of motion. 
 
 
Figure 3. Exercise testing protocol. The line indicates the target work rate profile that the 
participant was instructed to follow by actively producing forces. 
 
Measurements 
 
Cardiopulmonary response variables were monitored in real time using a breath-by-
breath system (MetaMax 3B, Cortex Biophysik GmbH, Germany). Pressure, volume and 
gas calibration was performed each day prior to testing according to the manufacturer’s 
recommendations: volume was calibrated using a volumetric syringe and gas was 
calibrated using a certified precision gas mixture. Heart rate (HR) was continuously 
measured and recorded by a chest belt (T31, Polar Electro, Kempele, Finland) and a 
receiver board (HRMI, Sparkfun, Boulder, USA). Subjects rated perceived exertion every 3 
minutes during the incremental phase using the Borg CR10 scale for dyspnea and leg 
fatigue. 
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Outcome measures and data analysis 
 
The cardiopulmonary performance parameters were calculated as follows: VO2peak was 
obtained from a 30‐second moving average of VO2 ; respiratory exchange ratio (RER) at 
VO2peak was also obtained from a 30‐second moving average value of RER; peak heart rate 
(HRpeak) was the highest heart rate value reached during the incremental exercise test 
protocol; peak work rate (WRpeak) was calculated from a 10-second moving average of the 
estimated work rate; the Borg CR10 scale for both exertion and leg fatigue was recorded at 
the time the subject reached their maximal performance; the slope of the VO2–WR 
relationship was calculated using data from 1 minute after the start of the ramp phase until 
1 minute before termination of the ramp phase. The time to VO2peak and the subjective 
reason for test termination were also recorded. The predicted HRpeak was calculated as  
220 – age and the predicted VO2peak for cycle ergometry was calculated based on the 
Wasserman et al. (1999) prediction. All analyses were performed using SPSS version 19 (IBM 
Corporation, USA). 
 
3. Results 
 
(i) Implementation. When subjects perform volitional muscle activation and increase their 
work rate, the electric motors in the RATT system operate in braking (generating) mode in 
order to resist the subject's force and maintain the pre-programmed joint trajectories. 
During initial tests, it was found that at high levels of work rate towards the end of the 
incremental phase the device's power supply was not able to buffer the excess energy 
produced, resulting in failure of the motors' servo-control electronics. To solve this 
problem, in order to buffer the excess energy produced during high levels of volitional 
muscular effort, the device's power supply unit was augmented with four shunt resistors 
connected in parallel (model DSR 50/5, Maxon Motor AG, Switzerland). Following this 
modification no further problems were encountered. 
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(ii) Responsiveness. All subjects showed substantial cardiopulmonary responses during 
the ramp phase of the protocol (Figure 4 – typical responses from one subject). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Typical peak cardiopulmonary responses from one subject during the ramp phase 
of the test protocol. (a) Target and measured work rates, (b) respiratory exchange ratio 
(RER), (c) oxygen uptake (V O2), (d) heart rate (HR). The plots of RER, V O2 and HR show 
averages over a 30s moving window. 
 
The outcome variables used for the responsiveness evaluation, averaged across all subjects, 
are summarised in Table 2. Resting VO2 was 4.6 ± 0.7 mL/min/kg and VO2peak was  
32.4 ± 5.1 mL/min/kg; this mean VO2peak was 81.1% of the predicted VO2peak for cycle 
ergometry (Wasserman et al., 1999). Resting HR was 80.3 ± 10.6 beats/min and HRpeak was 
177.5 ± 9.7 beats/min; all subjects reached at least 85% of their predicted HRpeak value. 
RER at VO2peak was 1.02 ± 0.07. 
 
WRpeak was 61.3 ± 15.1 W. The average maximal work rate achieved in males was  
65.7 W (n = 9) whereas in females it was 41.5 W (n = 2). The VO2 -WR relationship had a 
slope of 31.0 ± 4.5 mL/min/W. 
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All subjects rated the Borg CR10 scale of exertion and leg fatigue as more than 7, whereby 
the average value for leg fatigue was higher than that for exertion. The average duration of 
the incremental exercise phase was 8 min 48 s. Seven subjects achieved their maximal 
performance within the duration of 8-12 minutes. The reason given for termination was 
generalized fatigue in four subjects and leg fatigue in four subjects. Two subjects 
terminated the exercise because of breathing effort and one with foot pain. 
 
Table 2. Summary of outcome variables for responsiveness testing. 
 
 
Outcome Variable Value – mean (SD) 
Initial Rest Phase  
VO2 absolute [L/min] 0.31 (0.05) 
VO2 relative [mL/min/kg] 4.6 (0.7) 
HR [beats/min] 80.3 (10.6) 
Passive Phase  
VO2 absolute [L/min] 0.4 (0.1) 
VO2 relative [mL/min/kg] 6.1 (1.0) 
HR [beats/min] 83.7 (13.5) 
Warm Up Phase  
VO2 absolute [L/min] 0.8 (0.1) 
VO2 relative [mL/min/kg] 11.9 (2.4) 
HR [beats/min] 95.2 (10.7) 
Incremental Phase  
Peak VO2 absolute [L/min] 2.2 (0.5) 
Peak VO2 relative [mL/min/kg] 32.4 (5.1) 
Peak heart rate [beats/min] 177.5 (9.7) 
RER at peak VO2 1.02 (0.07) 
Borg CR10 scale exertion 8.1 (1.1) 
Borg CR10 scale leg effort 8.8 (0.9) 
Peak WR [W] 61.3 (15.1) 
Time to peak VO2 [min, s] 8, 48 (1, 42) 
VO2 ‐ WR relationship (slope) [mL/min/W] 30.95 (4.5) 
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4. Discussion  
 
The aim of the study was to assess the feasibility of the augmented RATT for peak 
cardiopulmonary performance testing using able-bodied subjects. Feasibility assessment 
focused on: (i) implementation (technical feasibility), and (ii) responsiveness (was there a 
measurable, high-level cardiopulmonary reaction?). 
 
(i) Implementation. The results show that it is technically feasible to employ the RATT 
system augmented with work rate estimation and a visual feedback system for peak 
cardiopulmonary performance testing. The addition of energy-buffering shunt resistors 
was required to cope with high levels of work rate occurring towards the end of the ramp 
phase, but only in the strongest members of the able-bodied subject group studied here. 
We judge it to be unlikely that this modification will be required when the device is 
employed in patients following neurological impairment because the patients are 
generally older and have additional motor weakness. 
 
(ii) Responsiveness. All subjects could understand the task and accurately follow the work 
rate target by means of the visual feedback system. For more than 70% of subjects, the 
duration of the incremental phase was in the range 8-12 minutes, which is the 
recommended time frame for incremental exercise testing (Buchfuhrer et al., 1983). No 
subject had an incremental-phase duration longer than 12 minutes, whereas the shortest 
duration was 6 min 30 s in one male subject. It remains important in future work to select 
the slope of the work rate increment to try and achieve the optimum duration of 8-12 
minutes. 
 
All subjects reached at least 85% of their predicted HRpeak, which implies adequate 
effort for an incremental exercise test (Balady et al., 2010;Guazzi et al., 2012). 
 
The average V O2peak of 32.4 mL/min/kg was 81.1% of the mean predicted peak value 
for cycle ergometry based on the Wasserman et al. (1999) prediction. However, this was 
not unexpected as the RATT provides support of most of the subject’s body weight and 
the pattern of movement in the RATT may not provoke such a high level of muscle 
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activity compared to cycle ergometry. Although the VO2peak was approximately 20% 
lower than in cycle ergometry, it still provoked a substantial oxygen uptake response and 
is higher than the VO2peak obtained from arm ergometry since the VO2peak obtained 
from arm ergometry was 30% lower (Astrand and Saltin, 1961). 
 
The recommended criteria for confirmation of a maximal VO2  response include a value 
for RER at peak of RER ≥ 1.10 (Stickland et al., 2012). Nine subjects in the present study did 
not fulfil this criterion and the average RER at peak was 1.02. Several factors may 
contribute to the low RER. Firstly, maximum performance may not have been reached as 
most subjects were unfamiliar with maximal exercise testing. Second, the tests may often 
have been terminated prematurely due to leg discomfort or fatigue. Third, the increment 
in work rate, therefore the incremental phase duration, may not have been optimal for 
each participant (Smith et al., 2006). 
 
The slope of the VO2 -WR relationship, i.e. the oxygen cost of the work, in the augmented 
RATT was 31 mL/min/W, which is higher than values reported for treadmill or cycle 
ergometers (Porszasz et al., 2003). However, compared to robotics-assisted treadmill 
exercise (Lokomat, Hocoma AG, Switzerland), the VO2 -WR slope from the RATT was 
lower (an average of 31  mL/min/W in the RATT compared to 41 mL/min/W in the 
robotics-assisted treadmill (Jack et al., 2010). The high VO2 -WR slope in the robotics-
assisted treadmill was attributed to a substantial amount of unaccounted work 
performed during the test (Jack et al., 2010). 
 
It was found that the VO2 during passive movement was only 1.3 times higher than 
resting VO2: passive movement in the RATT is clearly insufficient to provoke meaningful 
cardiopulmonary responses. This finding correlates with a previous study of passive 
walking during robotics-assisted treadmill exercise which demonstrated that passive 
walking increased oxygen uptake by a factor of only 1.4 relative to resting V O2 (Jack et 
al., 2011). The HR did not differ substantially between rest (80.3 beats/min) and passive 
movement (83.7 beats/min). Although the augmented RATT provides cyclical movement 
and pressure loading in an upright position, our findings show that passive movement 
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does not provide adequate cardiovascular loading at a level sufficient to improve 
cardiopulmonary fitness. It is clearly necessary to encourage patients to contribute 
volitional effort during training on the RATT to promote some cardiopulmonary 
reconditioning simultaneously with the neurorehabilitation, either via a visual feedback 
system or by verbal cueing. 
 
A major advantage of using the robotics-assisted tilt table for incremental exercise testing 
is the safe posture and whole-body support. Currently, the lack of appropriate support in 
other devices (e.g. cycle ergometer or treadmill) is one of the main factors that preclude 
exercise testing in severely affected neurological patients. The incorporation of force 
sensors, work rate calculation and a real time visual feedback system in the robotics-
assisted tilt table helps to guide each individual's exercise performance. The visual 
feedback is beneficial in the improvement of performance as patients receive direct and 
immediate feedback regarding their performance. 
 
There are some limitations associated with the robotics-assisted tilt table. The maximum 
cadence is 80 steps/min, which can be perceived as too slow at high work rates. The body 
support provided and the limited range of movement available leads to a lower level of 
muscle recruitment compared to treadmill exercise, thus contributing to the lower value 
of VO2peak observed. The stepping movement on the RATT differs from normal walking 
or cycling. However, the movement pattern is not complex and all subjects were able to 
adopt the movement pattern easily. 
 
Future work will focus on evaluating the test-retest reliability of performance testing with 
the augmented RATT. A direct comparison of peak cardiorespiratory performance values 
obtained from the RATT, a treadmill and a cycle ergometer in a single subject group will be 
conducted. The approach will then be tested in subjects with neurological impairments. 
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5. Conclusion 
 
The robotics-assisted tilt table augmented with work rate estimation and a visual 
feedback system is deemed feasible for peak cardiopulmonary performance testing: the 
approach was found to be technically implementable and substantial cardiopulmonary 
responses were observed. Based on this evidence using able-bodied subjects, the work-
rate-guided robotics-assisted tilt table approach is recommended for further testing 
within target groups of neurologically-impaired subjects. 
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Abstract 
 
The aim of the study was to compare the magnitude of peak cardiopulmonary performance 
parameters including peak oxygen uptake (VO2peak) and peak heart rate (HRpeak) obtained 
from a robotics-assisted tilt table (RATT), a cycle ergometer and a treadmill. The strength of 
correlations between the three devices, test-retest reliability and repeatability were also 
assessed. Eighteen healthy subjects performed six maximal exercise tests, with two tests on 
each of the three exercise modalities. Data from the second tests were used for the 
comparative and correlation analyses. For nine subjects, test-retest reliability and 
repeatability of VO2peak and HRpeak were assessed. Absolute VO2peak from the RATT, the cycle 
ergometer and the treadmill was (mean (SD)) 2.2 (0.56), 2.8 (0.80) and 3.2 (0.87) L/min, 
respectively (p < 0.001). HRpeak from the RATT, the cycle ergometer and the treadmill was 
168 (9.5), 179 (7.9) and 184 (6.9) beats/min, respectively (p < 0.001). VO2peak and HRpeak from 
the RATT vs the cycle ergometer and the RATT vs the treadmill showed strong correlations. 
Test-retest reliability and repeatability were high for VO2peak and HRpeak for all devices. The 
results demonstrate that the RATT has potential to be used for exercise testing where 
limitations exist for use of standard modalities. 
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1. Introduction 
 
Maximal oxygen uptake (VO2max) or peak oxygen uptake (VO2peak) are commonly used for the 
evaluation of physical fitness and for exercise prescription (Myers and Nieman, 
2010;Marzolini et al., 2012;Pescatello et al., 2014). The most commonly used devices are 
treadmills and cycle ergometers. The VO2max achieved from cycle ergometry has been 
observed to be 6-23% lower than from a treadmill (Buchfuhrer et al., 1983;Carter et al., 
2000;Porszasz et al., 2003). 
There are some limitations to the use of standard devices in neurological patients who have 
weakness or coordination problem caused by stroke, multiple sclerosis or spinal cord injury 
(Myers and Nieman, 2010). The alternative recommended devices for these patients are a 
semi-recumbent cycle ergometer or a total body stepper (Myers and Nieman, 2010), but 
severely affected patients have limitations that preclude them from using even these 
devices. 
Recent systematic reviews have highlighted the importance of maintaining cardiorespiratory 
fitness after stroke (Smith et al., 2012) and spinal cord injury (Jacobs and Nash, 2004), but 
also emphasise the technical difficulty of implementing testing protocols and training 
programmes in these populations. Smith et al. (2012) included 42 studies in their systematic 
review of cardiorespiratory fitness after stroke and reported that VO2peak was as low as 26% 
of that of healthy age- and gender-matched individuals; but, importantly, they noted that 
"most studies recruited patients with mild stroke" and pointed out that cardiorespiratory 
fitness is likely substantially lower in more severely affected patients. The reason for 
inclusion of only mildly-affected patients in the reviewed studies is clear: most studies 
estimated VO2peak using either a cycle ergometer or a treadmill, exercise modalities which 
are only usable in the case of mild to moderate impairment. 
Robotics-assisted tilt table provides the advantage of body support, cyclical stepping and 
physiological loading for early rehabilitation. This type of device has been augmented by 
adding force sensors, work rate calculation and a visual feedback system to guide exercise 
intensity for exercise testing (Bichsel et al., 2011). In a previous study, it was shown that it is 
feasible to measure peak cardiopulmonary performance parameters using the augmented 
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RATT (Saengsuwan et al., 2014;Laubacher et al., 2015). To verify that the device can be used 
to measure peak cardiopulmonary performance parameters, the RATT should be first be 
compared with the standard testing devices using able-bodied subjects.  
The aim of this study was to compare the magnitude of peak cardiopulmonary performance 
parameters including peak oxygen uptake (VO2peak) and peak heart rate (HRpeak) obtained 
from the RATT, a treadmill and a cycle ergometer. The strength of correlations between the 
devices, test-retest reliability and repeatability were also assessed. 
 
2. Materials and methods 
 
Subjects and general study design 
The study was reviewed and approved by the Ethics Review Board of the Canton of Bern in 
Switzerland (Reference No. 002/12). Written informed consent was obtained from all 
subjects prior to participation. The study was conducted in Bern University of Applied 
Sciences from December 2012 to September 2013.  
Eighteen subjects (10 male, 8 female) completed the study by performing 6 maximal exercise 
tests, with 2 tests on each of the three exercise modalities. Data from the second tests were 
used for the comparative and correlation analyses. For 9 subjects, test-retest reliability and 
repeatability analyses were carried out. The subjects had the following characteristics (mean 
(SD)): age 28.6 (6.3) years, height 172.4 (9.9) cm, body mass 69.1 (12.8) kg and body mass 
index 22.7 (2.2) kg/m2.  
Subjects performed a total of 6 tests using a treadmill (Venus, h/p/cosmos GmbH, Germany 
– 2 tests), a cycle ergometer (LC7, Monark Exercise AB, Sweden – 2 tests) and a RATT (Erigo, 
Hocoma AG, Switzerland – 2 tests). The test sessions were separated by at least 48 hours but 
not more than 7 days. The time of day for testing was the same for each subject. Participants 
were instructed to avoid strenuous activity within the 24 hours before testing and not to 
consume food, nicotine or caffeine at least three hours prior to testing (Myers et al., 
1991;Pina et al., 1995). The individualized, predicted maximum work rates for the treadmill 
and the cycle ergometer were calculated based on estimation of VO2max (Jurca et al., 2005). 
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The rate of increase in work rate was then calculated to achieve the predicted peak work 
rate in 10 minutes. 
Experimental procedures 
Each incremental exercise test had the same structure. There was 3 minutes of rest, 5 
minutes of warm up, a further 3 minutes of rest, and 3 minutes of unloaded movement. The 
ramp phase followed. Subjects then exercised until they reached their maximal performance 
and could not maintain the target work rate. Subjects were verbally encouraged to exercise 
to their limit of functional capacity. 
RATT: The subjects were first placed in a horizontal position on the tilt table and secured in 
accordance with the provisions of the support system. The thighs and the feet were fixed to 
the thigh cuffs and foot straps. The tilt table then was tilted to 70 degrees and the stepping 
movement was set at 80 steps/minute. Unloaded movement was achieved by subjects 
remaining passive while the RATT moved their legs. During the ramp phase, subjects were 
instructed to actively produce force by pushing into the leg cuffs. The target work rate and 
measured work rate were visually fed back to the subjects in real time on a computer screen 
(Figure 1). 
Cycle ergometer: The ramp phase was implemented by linearly increasing the work rate on 
the electromechanical brake. Unloaded movement was achieved by subjects cycling at 0 W. 
The cycle cadence throughout the test was freely selected but always above 60 rpm. The 
settings for the seat height, handlebar height and the seat to handlebar distance were 
adjusted to accommodate each subject. Each individual set up was recorded to ensure the 
same position in subsequent tests. 
Treadmill: Unloaded work was implemented using a low treadmill speed (0.9 km/h) and zero 
slope. During the ramp phase work rate was increased linearly every 30 seconds using 
combined non-linear changes in speed and slope (Hunt, 2008). 
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Figure 1. Work rate estimation and visual feedback. The subject's work rate is estimated 
continuously from forces in the thigh cuffs and joint angular velocities. A target work rate 
profile is displayed with the estimated work rate and the subject must adapt volitional 
muscular work to maintain the target. Physiological variables are monitored continuously. 
 
Measurements 
Cardiopulmonary response variables were monitored using a breath-by-breath system 
(MetaMax 3B, Cortex Biophysik GmbH, Germany). The device was calibrated prior to each 
test for volume and gas concentration using a 3-L syringe and a precision gas calibration 
mixture (15% O2 and 5% CO2). Heart rate was continuously measured using a chest belt (T31, 
Polar Electro, Finland) and recorded directly on the MetaMax system. Additionally, on the 
RATT, the heart rate was recorded using a receiver board (HRMI, Sparkfun, Boulder, USA). 
Subjects rated perceived exertion and leg fatigue every 3 minutes during the incremental 
exercise test using the Borg CR10 scale for dyspnea and leg fatigue (Borg, 1982;Borg, 1990).  
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Outcome measures 
Cardiopulmonary performance parameters were evaluated as follows: VO2peak was obtained 
from a 30-second moving average of VO2. Peak respiratory exchange ratio (RERpeak) was the 
average value of RER during the same period. Peak heart rate (HRpeak) was the maximal heart 
rate value reached during the incremental phase. VEpeak was a 30-second average of the 
peak minute ventilation. Peak work rate (WRpeak) was calculated from a 10-second average 
of the recorded work rate. The peak Borg CR10 scale for both dyspnea and leg fatigue were 
those recorded at the time that subjects reached their maximal performance. Time to 
VO2peak and the reasons for test termination were also recorded. 
Statistical analysis 
Data from the second test from each device were used for the comparative analysis among 
the three modalities. Normality of the data was assessed by the Kolmogorov-Smirnov test. 
Repeated measures analysis of variance (ANOVA) was conducted to determine whether 
there were significant differences between the peak cardiopulmonary performance 
parameters. If Mauchly’s test of sphericity was significant (p<0.05), Greenhouse-Geiser 
corrections were used. Bonferroni post-hoc multiple comparison corrections were applied to 
examine the differences between each paired data set, if a significant F ratio was found.  
For correlation analysis, linear regression of the VO2peak and HRpeak values for the RATT vs 
cycle ergometer and the RATT vs treadmill was performed. The regression equation, the 
correlation coefficient (R), the coefficient of determination (R2) and the standard error of 
estimate (SEE) were computed. 
Test-retest reliability of VO2peak and HRpeak on each device was analyzed using a 2-way, 
random intraclass correlation coefficient (ICC2,1) and a 95% confidence interval (CI). The 
within-subject variation of VO2peak and HRpeak was calculated using the coefficient of variation 
(Bland and Altman, 1996). The Bland and Altman limits of agreement were used to 
investigate the repeatability of VO2peak and the HRpeak on each device. All analyses were 
performed using SPSS (Version 19.0, IBM Corp.).  
 
33 
 
3. Results 
Comparison of peak values 
Overall, statistically significant differences in all peak performance parameters, except in the 
Borg CR10 scale for leg effort, were seen between the RATT, the cycle ergometer and the 
treadmill (Table 1). 
Absolute VO2peak from the RATT, the cycle ergometer and the treadmill was (mean (SD)) 2.2 
(0.56), 2.8 (0.80) and 3.2 (0.87) L/min, respectively (p < 0.001). Absolute VO2peak obtained 
from the RATT was on average 19.0% lower than the cycle ergometer and 29.2% lower than 
on the treadmill. 
HRpeak from the RATT, the cycle ergometer and the treadmill was 168 (9.5), 179 (7.9) and 184 
(6.9) beats/min, respectively (p < 0.001). HRpeak obtained on the RATT was on average 6.0% 
lower than the cycle ergometer and 8.6% lower than on the treadmill.  
Table 1. Peak performance values from the RATT, cycle and treadmill (n=18).  
Variables RATT cycle 
ergometer 
treadmill  
 
P value 
VO2peak absolute (L/min)a, b, c 2.24 ± 0.56 2.81 ± 0.80 3.19 ± 0.87 <0.001 
VO2peak relative (mL/kg/min) a, b, c 32.3 ± 4.9 40.2 ± 7.0 45.9 ± 7.6 <0.001 
HRpeak (beats/min) a, b, c 168.0 ± 9.5 178.8 ± 7.9 183.8 ± 6.9 <0.001 
Percent predicted HRpeak (%) a, b, c 87.8 ± 5.3 93.5 ± 4.8 96.1 ± 4.2 <0.001 
RERpeak a, b 1.03 ± 0.1 1.13 ± 0.1 1.11 ± 0.1 <0.001 
VEpeak (L/min) a, b, d (n=17) 72.2 ± 21.1 101.4 ± 31.0 106.1 ± 32.0 <0.001 
Borg CR10 scale dyspnea b, d 6.6 ± 2.0 7.6 ± 1.7 9.1 ± 0.6 <0.001 
Borg CR10 scale leg effort 8. 8 ± 1.4 9.0 ± 1.6 9.1 ± 1.0 0. 65 
WRpeak (W) a, b, c 65.9 ± 18.0 233.5 ± 72.7 205.9 ± 70.1 <0.001 
Time to VO2peak (min) 9.9 ± 1.0 9.7 ± 1.2 9.0 ± 1.1 0.063 
Data are given as mean ± standard deviation. VO2 = oxygen uptake, VO2peak = peak oxygen uptake, 
HRpeak = peak heart rate, Percent predicted HRpeak = the peak heart rate expressed as a percentage of 
the predicted peak heart rate, RERpeak = peak respiratory exchange ratio, VEpeak = peak minute 
ventilation, WRpeak = peak work rate.; a p < 0.001 between the RATT and the cycle ergometer; b p < 
0.001 between the RATT and the treadmill; c p < 0.001 between the cycle ergometer and the 
treadmill, d p< 0.05 between the cycle ergometer and the treadmill. 
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The three most common reasons given by the subjects for stopping the RATT test were leg 
fatigue (66.7%), generalized fatigue (11.1%) and leg discomfort at high work rate (11.1%). 
Two subjects reported foot pain due to tight foot strap fixation, which immediately resolved 
after the straps were released following the test. The main reasons for stopping the test on 
the treadmill were breathing effort (44.4%), generalized fatigue (33.3%), and leg fatigue 
(16.6%). The main reasons for stopping the cycle test were leg fatigue (66.7%), generalized 
fatigue (16.7%) and breathing effort (11.1%). No other complaints or immediate 
complications after the exercise testing were observed. 
Correlation analysis 
Linear regression analysis revealed very strong positive correlations between the RATT vs the 
cycle ergometer VO2peak (r=0.95. p<0.001) and the RATT vs the treadmill VO2peak (r=0.94. 
p<0.001) (Figure 2). There were strong positive correlation between the RATT HRpeak vs the 
cycle ergometer HRpeak (r=0.64, p<0.005) and the RATT HRpeak vs the treadmill HRpeak (r=0.62, 
p<0.05) (Figure 3). 
 
Figure 2. Linear regression analysis of VO2peak (peak oxygen uptake): (a) RATT vs cycle, and 
(b) RATT vs treadmill. The equation, the correlation coefficient (R), the coefficient of 
determination (R2) and the standard error of estimation (SEE) are shown. The regression line 
is shown in each graph. 
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Figure 3. Linear regression analysis of HRpeak: (a) RATT vs cycle, and (b) RATT vs treadmill. The 
equation, the correlation coefficient (R), the coefficient of determination (R2) and the 
standard error of estimation (SEE) are shown. The regression line is shown in each graph. 
Test-retest reliability and repeatability  
VO2peak and HRpeak measured with all 3 devices had very high test-retest reliability with ICC2,1 
≥ 0.85 (Table 2). The coefficient of variation of the VO2peak and HRpeak was less than 5% in all 
devices. The Bland and Altman analysis showed similar limits of agreement among the 
devices (Table 2). 
Table 2. Test-retest reliability and repeatability of each device (n=9). 
 Overall mean 
(tests 1 and 2) 
MD (95% LoA) CoV (%) ICC (95% CI) 
VO2peak (L/min)     
RATT 2.152 0.026 (-0.268, 0.320) 4.1 0.97 (0.89-0.99) 
cycle ergometer 2.622 0.056 (-0.238, 0.342) 3.3 0.98 (0.94-1.00) 
treadmill 2.924 0.013 (-0.271, 0.305) 2.4 0.99 (0.95-1.00) 
HRpeak (beats/min)     
RATT 169.0 0.67 (12.57, -11.23) 1.8 0.89 (0.58-0.97) 
cycle ergometer 180.3 2.56 (-5.77, 10.89) 1.6 0.86 (0.48-0.97) 
treadmill 185.3 2.38 (-2.67, 7.33) 0.9 0.89 (0.40-0.98) 
MD, mean difference; LoA, limits of agreement; CoV, coefficient of variation; ICC, intraclass 
correlation coefficient; CI, confidence interval; VO2peak, peak oxygen uptake; HRpeak, peak heart rate. 
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4. Discussion 
 
The aim in the present study was to compare the magnitude of peak cardiopulmonary 
performance parameters including oxygen uptake (VO2peak) and peak heart rate (HRpeak) 
obtained from the RATT, a treadmill and a cycle ergometer. It was also an aim to assess the 
strength of correlations between the devices, test-retest reliability and repeatability. 
The results demonstrate that VO2peak on the treadmill and the cycle ergometer is higher than 
on the RATT. On average, the VO2peak values obtained from the RATT were 81.0% of the cycle 
ergometer VO2peak and 70.8% of the treadmill VO2peak. 
There were strong correlations between the RATT vs the cycle ergometer and the RATT vs 
the treadmill VO2peak. These results are comparable to the correlation of treadmill vs total 
body recumbent stepper VO2peak (r= 0.92) (Billinger et al., 2008a) and the correlation of arm 
ergometer vs treadmill VO2peak (r=0.85) (Schrieks et al., 2011). Both the cycle ergometer and 
treadmill have been validated as standard devices for estimation of peak cardiopulmonary 
performance parameters. The high correlation coefficients of VO2peak between the devices 
investigated here suggests that the RATT, similarly, is a valid device for peak exercise testing 
within and between subjects. There is potential for the RATT to serve as an alternative to the 
cycle ergometer and treadmill for the estimation of VO2peak in severely impaired subjects 
who cannot use the standard modalities. 
An alternative device for investigation of cardiopulmonary performance in impaired subjects 
is the supine cycle ergometer (Simonson and Wyatt, 2003). Comparing the VO2peak obtained 
from the RATT and the published data for the supine cycle ergometer, the RATT value is 
lower than the supine cycle ergometer: the supine cycle ergometer was approximately 22% 
lower than the treadmill VO2peak in normal subjects (Simonson and Wyatt, 2003). The 
difference in the movement pattern on the RATT may account for the lower VO2peak on the 
RATT. However, neurological patients who have severe weakness or spasticity may have 
difficulty pedaling on the supine cycle ergometer because there is no leg support.  
The RATT appears to be able to provoke higher VO2peak compared to arm ergometry. VO2peak 
obtained from arm ergometry in healthy subjects was 42-43% lower than the treadmill 
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VO2peak (Schrieks et al., 2011) and 30-34% lower than the cycle ergometry VO2peak (Astrand 
and Saltin, 1961;Reybrouck et al., 1975;Orr et al., 2013). 
Regarding test-retest reliability, the ICC for VO2peak from each device is high. The lower limit 
of the 95% CI of the ICC for each device was more than 0.75, which is considered good 
reliability (Lee et al., 1989;Tammemagi et al., 1995). Furthermore, the VO2peak obtained from 
each device has high repeatability as determined by the Bland-Altman limits of agreement. 
The repeatability data were more precise than in a study of the repeatability of VO2peak from 
the arm-leg ergometer as tested in healthy subjects (bias ± 1.96 SD = 0.016 ± 0.74 L/min) 
(Simmelink et al., 2009). The within-subject coefficients of variation for VO2peak and HRpeak 
were comparable to previous studies using cycle ergometry and treadmill exercise (Garrard 
and Emmons, 1986;Nordrehaug et al., 1991). 
HRpeak obtained from the RATT was lower than HRpeak from the treadmill and the cycle 
ergometer. Although strong correlations between the RATT vs cycle HRpeak and the RATT vs 
treadmill HRpeak were found, the correlation coefficient (R) and the coefficient of 
determination (R2) are lower compared to those for VO2peak. The R2 values found in this study 
(0.41 for the cycle, 0.39 for the treadmill) are slightly higher than in a study of Shrieks et al. 
(2011), who compared a treadmill with an arm crank ergometer and found that a linear 
regression for HRpeak for treadmill vs arm crank ergometer had R2 = 0.33, which reflects that 
there are some factors which influence HRpeak other than the effect of the device itself. 
Previous work showed that age explained the majority of the variance (Fairbarn et al., 
1994;Tanaka et al., 2001). Other factors such as sex are controversial: Tanaka et al. (2001) 
stated that age predicted maximal heart rate to a large extent and that HRpeak is independent 
of gender or physical activity status; however, Faff et al. (2007) found a significant sex-
dependent difference in the regression formula obtained after exercise on the treadmill and 
the cycle ergometer in athletes. 
Repeatability of HRpeak from the RATT is comparable to the cycle ergometer. It was more 
precise compared to the study of Simmerlink et al. (2009), in which HRpeak repeatability from 
an arm-leg ergometer was 2.83 ± 19.85 beats/min. Although the point estimates of ICC of 
the HRpeak from all devices studied here were high and comparable, the 95% CI were wide. 
Overall, the HRpeak parameter was seen to be less reliable than VO2peak. 
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A limitation of the present study is that, since a direct comparison between the devices in 
moderately or severely disabled neurological patients is not possible, it remains unknown 
whether the relative peak cardiopulmonary performance parameters can be extrapolated to 
the target patient population. 
The data presented here, in particular the high correlation with standard devices and the 
high test-retest reliability and repeatability, support the validity of the RATT as a means of 
estimating peak cardiopulmonary performance parameters. The results demonstrate that 
the RATT has potential to be used for exercise testing in patients who have limitations for 
use of standard exercise testing modalities. The visual feedback system may be beneficial for 
the motivation of patients in both exercise testing and prescriptive exercise training. Future 
work should focus on the feasibility of peak cardiopulmonary performance testing using the 
RATT in populations with severe neurological impairments. 
 
5. Conclusions 
 
The present study demonstrated that VO2peak from the RATT was   2̴0% lower than the cycle 
ergometer and   3̴0% lower than the treadmill. The magnitude of difference is less than the 
arm ergometer (Astrand and Saltin, 1961;Schrieks et al., 2011) but more than the supine 
cycle ergometer (Simonson and Wyatt, 2003). The high correlation coefficients, the high 
test-retest reliability and the high repeatability of the VO2peak suggest that the RATT has 
potential to be used for exercise testing where limitations exist for use of standard 
modalities. 
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Abstract 
 
Background. The robotics-assisted tilt table (RATT), including actuators for tilting and cyclical 
leg movement, is used for rehabilitation of severely disabled neurological patients. Following 
further engineering development of the system, i.e. the addition of force sensors and visual 
bio-feedback, patients can actively participate in exercise testing and training on the device. 
Peak cardiopulmonary performance parameters were previously investigated, but it also 
important to compare submaximal parameters with standard devices. The aim of this study 
was to evaluate the feasibility of the RATT for estimation of submaximal exercise thresholds 
by comparison with a cycle ergometer and a treadmill. 
Methods. 17 healthy subjects randomly performed six maximal individualized incremental 
exercise tests, with two tests on each of the three exercise modalities. The ventilatory 
anaerobic threshold (VAT) and respiratory compensation point (RCP) were determined from 
breath-by-breath data. 
Results. VAT and RCP on the RATT were lower than the cycle ergometer and the treadmill: 
oxygen uptake (V'O2) at VAT was (mean (SD)) 1.2 (0.3), 1.5 (0.4) and 1.6 (0.5) L/min, 
respectively (p<0.001); V'O2 at RCP was 1.7 (0.4), 2.3 (0.8) and 2.6 (0.9) L/min, respectively 
(p=0.001). 
High correlations for VAT and RCP were found between the RATT vs the cycle ergometer and 
RATT vs the treadmill (R on the range 0.69 to 0.80). VAT and RCP demonstrated excellent 
test-retest reliability for all three devices (ICC from 0.81 to 0.98). Mean differences between 
the test and retest values on each device were close to zero. 
The ventilatory equivalent for O2 at VAT for the RATT and cycle ergometer were similar and 
both were higher than the treadmill. The ventilatory equivalent for CO2 at RCP was similar 
for all devices. Ventilatory equivalent parameters demonstrated fair-to-excellent reliability 
and repeatability. 
Conclusions. It is feasible to use the RATT for estimation of submaximal exercise thresholds: 
VAT and RCP on the RATT were lower than the cycle ergometer and the treadmill, but there 
were high correlations between the RATT vs the cycle ergometer and vs the treadmill. 
Repeatability and test-retest reliability of all submaximal threshold parameters from the 
RATT were comparable to those of standard devices. 
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1. Background 
 
A robotics-assisted tilt table (RATT) provides safe mobilization and intensive sensorimotor 
stimulation for early rehabilitation of neurological patients by tilting the patient upright and 
implementing cyclical leg stepping movement. The RATT has separate actuators for tilting 
the table and for continuously moving the legs during therapy.  
 
The RATT device employed in the present work is a clinical product (Erigo, Hocoma AG, 
Switzerland), which as standard includes neither measurement of the patient’s work rate, 
nor does it provide the patient with any form of biofeedback which could be used to guide 
their active participation. To extend the functionality of the standard RATT, specifically to 
make it possible to implement formal exercise testing protocols on the device, the RATT was 
augmented with force sensors and a visual bio-feedback system (Bichsel et al., 2011). The 
force sensors were inserted under the leg cuffs which attach the patient’s legs to the leg-
drive systems. Using additional measurements of the moment arms and the joint angular 
velocities, the true work rate (in Watts) applied by the patient at the human-machine 
interface can be calculated in real time. The new visual biofeedback system which was added 
to the standard device shows the patient a target work rate and, in real time, the actual, 
measured work rate. The patient is instructed to adapt their volition leg effort, by producing 
forces into the leg cuffs in synchrony with the cyclical leg motion, in order to follow the work 
rate target as closely as possible. The target work rate can be chosen arbitrarily, but, for 
exercise testing purposes, it will be a standardized test protocol such as a constant work rate 
or incremental ramp. These engineering extensions have enabled severely disabled 
neurological patients to actively participate in exercise testing and training on the RATT 
(Laubacher et al., 2015;Saengsuwan et al., 2015a).  
 
The augmented RATT device, with the engineering developments outlined above, makes 
possible for the first time the implementation of standardized exercise testing protocols on a 
robotics-assisted tilt table for determination of the key parameters of cardiopulmonary 
status (testing) and to allow optimized prescription of exercise regimes (training). An 
incremental exercise test, where the patient’s work rate increases linearly over a short time 
period, delivers two types of parameters: (i) peak cardiopulmonary performance parameters 
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(peak oxygen uptake and peak heart rate), which characterize aerobic capacity, and (ii) 
submaximal exercise thresholds (primarily the ventilatory anaerobic threshold, VAT, and 
respiratory compensation point, RCP), which serve mainly to allow prescription of training 
intensity. 
 
We previously reported on peak cardiopulmonary performance parameters (parameter 
group (i), above) obtained using the augmented RATT, and compared peak responses from 
the augmented RATT with standard modalities (treadmill and cycle ergometers) 
(Saengsuwan et al., 2015b). In the present work, we investigate the second major parameter 
group, (ii) above, which can be obtained from incremental exercise testing, viz. the 
submaximal exercise thresholds VAT and RCP, together with several secondary submaximal 
parameters. The submaximal parameters from the RATT are directly compared with values 
obtained in the same subjects using treadmill and cycle ergometers. This investigation is 
considered clinically relevant because most neurological patients such as those with stroke 
or multiple sclerosis often terminate exercise testing before their maximal effort is reached. 
Non-cardiopulmonary factors, such as cognitive problems, muscle weakness or fatigue, are 
the causes linked to exercise termination in these patients (Koseoglu et al., 2006;Tang et al., 
2013a). 
 
The submaximal exercise thresholds, i.e. the oxygen uptake at the ventilatory anaerobic 
threshold (V'O2@VAT) and at the respiratory compensation point (V'O2@RCP), are important 
because they can provide crucial information for the assessment of fitness status (Weston 
and Gabbett, 2001;American Thoracic Society, 2003;Maciejczyk et al., 2014) or for exercise 
prescription (Meyer et al., 2005;Binder et al., 2008;Mezzani et al., 2013). They are 
independent of subjects’ motivation (Agostoni et al., 2005) and the duration of the exercise 
testing protocol (Buchfuhrer et al., 1983). Furthermore, V'O2@VAT is reported to be useful for 
follow up after an intervention (Ready and Quinney, 1982;Sullivan et al., 1989;Nishijima et 
al., 1993), for the prediction of all-cause postoperative mortality (Wilson et al., 2010) and for 
the assessment of the severity of heart failure (Matsumura et al., 1983). 
 
Other submaximal exercise parameters derived from ventilation (V'E), such as ventilatory 
equivalent of oxygen (V'E/V'O2), ventilatory equivalent of carbon dioxide (V'E/V'CO2) and the 
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V'E-vs-V'CO2 slope, provide additional information regarding the existence and severity of 
heart and lung diseases (Wasserman et al., 1999;Sun et al., 2001). Additionally, V'E/V'CO2 
and the V'E-vs-V'CO2 slope are important predictors for mortality in some groups of patients, 
e.g. patients with heart failure (Arena et al., 2004;Myers et al., 2009). 
 
Numerous studies reported differences in submaximal exercise parameters on the cycle 
ergometer and the treadmill (Buchfuhrer et al., 1983;Sun et al., 2002;Porszasz et al., 
2003;Davis et al., 2006b), the arm ergometer and the cycle ergometer (Orr et al., 
2013;Loughney et al., 2014), and the arm ergometer, the cycle ergometer and the treadmill 
(Davis et al., 1976). It has been shown that the submaximal thresholds, e.g. V'O2@VAT, from 
the arm ergometer were lower than the cycle ergometer, and V'O2@VAT from the cycle 
ergometer was lower than the treadmill (Buchfuhrer et al., 1983;Porszasz et al., 2003;Orr et 
al., 2013;Loughney et al., 2014). Regarding submaximal exercise parameters such as 
V'E/V'CO2 and the V'E-vs-V'CO2 slope, there are conflicting data. Sun et al. (2002) reported 
no mode-dependent difference in V'E/V'CO2 and the V'E-vs-V'CO2 slope; however, Davis et 
al. (2006b) found that V'E/V'CO2 and the V'E-vs-V'CO2 slope were higher on the treadmill 
than the cycle ergometer in women but not in men, and concluded that women 
demonstrated mode dependency in ventilatory efficiency indices. 
 
Since there are no previous data regarding the comparative evaluation of submaximal 
exercise parameters from the RATT, the aim of this study was to evaluate the feasibility of 
the RATT for estimation of submaximal exercise thresholds and to compare these with the 
cycle ergometer and the treadmill. 
 
2. Materials and methods 
 
Study design and selection criteria 
 
This descriptive study was reviewed and approved by the Ethics Review Committee of the 
Swiss Canton of Bern, Switzerland (Reference No. 002/12). All research subjects gave their 
written informed consent before participating in the study.  
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Subjects were included in the study if they were 18-50 years and had no history of 
cardiovascular, pulmonary and musculoskeletal disease that might have interfered with the 
exercise testing. 
 
Testing procedures 
 
Subjects were randomly assigned to perform six maximal individualized incremental exercise 
tests, with two tests on each of the three exercise modalities: a treadmill (Venus, 
h/p/cosmos GmbH, Germany – 2 tests), a cycle ergometer (LC7, Monark Exercise AB, 
Sweden – 2 tests) and a robotics-assisted tilt table (RATT; Erigo, Hocoma AG, Switzerland – 2 
tests) (Saengsuwan et al., 2015b). Each test session was separated by at least 48 hours but 
not more than 7 days and the time of day was controlled. Subjects were advised to avoid 
strenuous activity for at least 24 hours and not to consume food for at least 3 hours before 
the exercise testing (Pina et al., 1995). 
 
The incremental exercise testing protocol on each device was the same: it started with 3 
minutes of rest, 5 minutes of warm up, 3 minutes of rest, and 3 minutes of unloaded 
movement before the ramp phase (Figure 1). Subjects’ work rate increments during the 
ramp phase were estimated from their predicted maximal oxygen uptake (Jurca et al., 2005) 
in order that the subjects would reach their maximal exercise performance in 8-12 minutes 
(Buchfuhrer et al., 1983). 
 
Figure 1. Incremental exercise testing protocol for all three devices. 
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RATT: The subjects were first secured with a body harness, thigh cuffs and foot straps. Then 
the RATT was tilted to 70 degrees and the stepping movement was set at 80 steps/minute, 
which is the maximal achievable step rate on this device. The RATT ramp rate was set in the 
range of 4 to 12 W/min. The subjects were instructed to actively push into the leg cuffs to 
produce force to follow the target work rate which they could see and compare to their 
actual work rate in real time (Figure 2).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Robotics-assisted tilt table (RATT) with visual feedback system. The visual feedback 
screen shows the target work rate and the subject’s work rate. The subject’s work rate was 
calculated from the forces in the thigh cuffs and the angular velocities. 
 
Cycle ergometer: The ramp rate ranged from 12 to 40 W/min. The settings for the seating 
and pedalling were adjusted for each subject and recorded to ensure the same position in 
subsequent tests. 
 
Treadmill: During the ramp phase, the work rate increment ranged from 14 to 30 W/min. 
The work rate was increased linearly every 30 seconds using combined non-linear changes in 
speed and slope (Hunt, 2008). 
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Cardiopulmonary data were recorded with a breath-by-breath cardiopulmonary testing 
system (MetaMax 3B, Cortex Biophysik GmbH, Germany). Before each test, full calibration 
was performed: pressure calibration; volume calibration with a 3-L syringe; and two-point 
gas calibration using ambient air and a precision gas mixture (15% oxygen and 5% carbon 
dioxide). Heart rate was recorded using a chest strap (model T34, Polar Electro Oy, Finland). 
The cardiopulmonary variables were analysed using a 15-breath average on the 
corresponding Metasoft software (version 2.7.29, Cortex Biophysik GmbH, Germany) 
(Robergs et al., 2010). 
 
Outcome measures 
 
The VAT and RCP were identified according to the criteria suggested by Binder et al (2008). 
The VAT was visually determined using the combination of these approaches: (1) the point 
of deflection of V'CO2 versus V'O2 (V-slope method) (Beaver et al., 1986); (2) the point where 
V'E/V'O2 reaches its minimum or starts to rise without a rise in V'E/V'CO2; and, (3) the point 
at which partial pressure of end-tidal oxygen tension (PETO2) reaches a minimum or starts to 
rise without a decline in the partial pressure of end-tidal carbon dioxide tension (PETCO2). 
The RCP was visually determined by: (1) the point of deflection of V'E versus V'CO2; (2) the 
minimal value or nonlinear rise of V'E/V'CO2; and, (3) the point that PETCO2 starts to decline. 
The above approaches were used to determine the values of V'O2 and V'E/V'O2 at VAT 
(V'O2@VAT and V'E/V'O2@VAT), and V'O2 and V'E/V'CO2 at RCP (V'O2@RCP and V'E/V'CO2@RCP). 
The slope of V'E-vs-V'CO2 from the start of the ramp phase to the RCP was also estimated. 
 
Statistical analysis 
 
Normality of the data was assessed by the Shapiro-Wilk test. Data from the second tests on 
each device were used for the comparative and correlation analyses. Repeated measures 
analysis of variance (ANOVA) was conducted to determine whether there were differences 
of V'O2@VAT and V'O2@RCP between the three devices. If a statistically significant difference 
was found, Bonferroni post-hoc multiple comparison corrections were applied to examine 
differences between each paired data set. 
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Linear regression analysis was used to identify the correlation between the values of 
V'O2@VAT and V'O2@RCP on the RATT vs cycle ergometer and vs treadmill. The regression 
equation, correlation coefficient (R), coefficient of determination (R2) and standard error of 
the estimate (SEE) were obtained. 
Test-retest reliability of submaximal parameters on each device was analysed using a 2-way 
mixed single measures (absolute agreement) intraclass correlation coefficient (ICC3,1) (Weir, 
2005). 0.40 ≤ ICC < 0.75 was considered as fair to good reliability and ICC ≥ 0.75 was 
considered excellent reliability (Rosner, 2010). Repeatability was analysed using the Bland 
and Altman limits of agreement, incorporating mean difference and coefficient of 
repeatability (Bland and Altman, 1986). The within-subject coefficients of variation were also 
calculated (Bland and Altman, 1996). The test-retest reliability was based on only 9 subjects 
because of a technical problem in the measurement device detected in the data from the 
first tests in 8 subjects. All analyses were performed using SPSS (Version 19.0, IBM Corp.). 
 
3. Results 
 
Seventeen subjects were included (9 male, 8 female). The subjects had the following 
characteristics (mean (SD)): age 28.4 (6.4) years, height 171.8 (9.8) cm, body mass 68.1 
(12.5) kg and body mass index 22.6 (2.2) kg/m2.  
 
VAT and RCP 
 
The VAT was able to be identified in all subjects on all three devices. The RCP on the RATT 
was identified in 10 subjects (58.8%), on the cycle ergometer in 17 subjects (100%), and on 
the treadmill in 15 subjects (88.2%); in 9 subjects, the RCP was identified for all three 
devices. 
The V'O2@VAT and V'O2@RCP from the RATT were lower than the cycle ergometer and the 
treadmill: absolute V'O2@VAT from the RATT, the cycle ergometer and the treadmill was 
(mean (SD)) 1.2 (0.3), 1.5 (0.4) and 1.6 (0.5) L/min, respectively (p<0.001); V'O2@RCP from the 
RATT, the cycle ergometer and the treadmill was 1.7 (0.4), 2.3 (0.8) and 2.6 (0.9) L/min, 
respectively (p=0.001) (Table 1, Figure 3). On average, the V'O2@VAT on the RATT was 21.4% 
lower than the cycle ergometer V'O2@VAT and 26.1% lower than the treadmill V'O2@VAT (mean 
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individual differences). The V'O2@RCP on the RATT was 23.9% lower than the cycle ergometer 
V'O2@RCP and 30.6% lower than the treadmill V'O2@RCP (mean individual differences). 
 
Table 1. Submaximal performance parameters from the RATT, cycle and treadmill (VAT: 
n=17; RCP: n=9). 
 
Variables RATT Cycle 
ergometer 
Treadmill p value 
V'O2peak absolute (L/min) a, b, c (n=17) 2.39 ± 0.6 2.82 ± 0.8 3.2 ± 0.9 <0.001 
Absolute V'O2@VAT (L/min) a,b (n=17) 1.16 ± 0.3 1.53 ± 0.4 1.64 ± 0.5 <0.001 
Relative V'O2@VAT (mL/kg/min) a,b 17.2 ± 3.6 22.3 ± 4.0 23.8 ± 4.7 <0.001 
V'O2@VAT as % of V'O2peak 49.4 ± 8.8 54.5 ± 5.1 50.6 ± 5.9 0.047 
HR at VAT (beats/min) a 114.3 ± 12.9 125.3 ± 10.6 121.7 ± 12.8 0.007 
HR at VAT as percent predicted HRpeak (%) a 59.6 ± 6.3 65.4 ± 4.8 63.5 ± 5.9 0.007 
Absolute V'O2@RCP (L/min) a, b, c (n=9) 1.68 ± 0.4 2.26 ± 0.8 2.55 ± 0.9 0.001 
Relative V'O2@RCP (mL/kg/min) a, b 24.9 ± 5.1 33.0 ± 7.5 37.3 ± 9.3 <0.001 
V'O2@RCP as % of V'O2peak a 68.7 ± 10.2 78.5 ± 9.9 79.1 ± 15.6 0.022 
HR at RCP (beats/min) a 141.3 ± 17.5 153.2 ± 18.1 158.7 ± 21.9 0.004 
HR at RCP as percent predicted HRpeak (%) a 73.6 ± 7.1 79.8 ± 6.9 82.6 ± 9.0 0.003 
V'E/V'O2@VAT b,c (n=17) 23.6 ± 2.9 23.8 ± 3.0 21.8 ± 2.2 0.002 
V'E/V'CO2@RCP (n=9) 28.9 ± 2.3 27.5 ± 2.8 26.7 ± 2.9 0.022 
V'E-vs-V'CO2 slope to RCP a,b (n=9) 28.4 ± 2.8 26.4 ± 2.4 25.7 ± 2.7 0.002 
Data are given as mean ± standard deviation. V'O2peak = peak oxygen uptake, V'O2 = oxygen uptake, 
VAT = ventilatory anaerobic threshold, V'O2@VAT = V'O2 at VAT, HR = heart rate, HRpeak = peak heart 
rate, RCP = respiratory compensation point, V'O2@RCP = V'O2 at RCP, V'E/V'O2@VAT = ventilatory 
equivalent of oxygen at VAT, V'E/V'CO2@RCP = ventilatory equivalent of carbon dioxide at RCP, V'E-vs-
V'CO2 slope = ventilation versus carbon dioxide output slope.  
a p < 0.05 between the RATT and the cycle ergometer; b p < 0.05 between the RATT and the treadmill; 
c p < 0.05 between the cycle ergometer and the treadmill. 
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Figure 3. Box plots for VO2@VAT, VO2@RCP and VO2peak among the 3 devices. Asterisks represent 
significant differences in each paired data set assessed by Bonferroni post-hoc multiple 
comparison corrections. 
 
High correlations were found between the RATT vs the cycle ergometer V'O2@VAT (R=0.70, 
p<0.01) and V'O2@RCP (R=0.80, p<0.01). The RATT vs the treadmill V'O2@VAT (R=0.73, p<0.01) 
and V'O2@RCP (R=0.69, p<0.05) demonstrated similarly high correlations (Figure 4). The 
V'O2@VAT and V'O2@RCP demonstrated excellent test-retest reliability for all three devices (ICC 
0.81-0.98). The mean differences between the test and retest values on each device were 
close to zero (Table 2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Linear regression analysis of VO2@VAT (a,b) and VO2@RCP (c,d) on the RATT vs the 
cycle ergometer and the RATT vs the treadmill.   
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Table 2. Test-retest reliability of the submaximal performance parameters from the RATT, 
cycle and treadmill. 
 
 Overall mean 
(tests 1 and 2) 
MD (95% LoA) CoV (%) ICC (95% CI) SEM %SEM 
V'O2@VAT (mL/min) (n=9)        
RATT  1.129 -0.047 (-0.225, 0.131) 5.91 0.92 (0.60-0.98) 0.064 5.67 
Cycle ergometer  1.411 0.082 (-0.459, 0.624) 14.10 0.81 (0.39-0.95) 0.195 13.82 
Treadmill  1.561 -0.015 (-0.290, 0.259) 6.78 0.98 (0.90-1.0) 0.099 6.34 
V'O2@RCP (L/min)       
RATT (n=6) 1.649 0.094 (-0.208, 0.395) 6.52 0.92 (0.52-0.99) 0.109 6.61 
Cycle ergometer (n=8) 2.344 -0.014 (-0.706, 0.678) 8.66 0.87 (0.47-0.97) 0.245 10.45 
Treadmill (n=7) 2.609 -0.069 (-0.640, 0.502) 7.17 0.95 (0.74-0.99) 0.206 7.90 
V'E/V'O2@VAT(n=9)       
RATT 23.7 -0.01 (-3.5, 3.5) 5.02 0.70 (0.10, 0.93) 1.26 5.31 
Cycle ergometer  23.4 1.46 (-4.3,  7.2) 9.78 0.62 (0.05, 0.90) 2.07 8.87 
Treadmill  21.7 0.20 (-2.5, 2.9) 4.33 0.74 (0.19, 0.94) 0.97 4.47 
VE/V'CO2@RCP (L/min)       
RATT (n=6) 28.8 0.70 (-1.0, 2.4) 2.48 0.77 (0.03, 0.97) 0.62 2.16 
Cycle ergometer (n=8) 27.7 1.24 (-1.2, 3.6) 4.80 0.90 (0.33, 0.98) 0.86 3.10 
Treadmill (n=7) 26.4 -0.97 (-4.6, 2.6) 5.23 0.71 (0.09, 0.94) 1.30 4.92 
V'E-vs-V'CO2 slope to RCP        
RATT (n=6) 28.0 0.73 (-4.0, 5.5) 6.00 0.53 (-0.38, 0.92) 1.71 6.11 
Cycle ergometer (n=8) 26.4 2.19 (-2.0, 6.4) 8.26 0.75 (0.04, 0.95) 1.52 5.77 
Treadmill (n=7) 25.4 -1.14 (-4.3, 2.1) 5.13 0.74 (0.12, 0.95) 1.15 4.54 
MD = mean difference, LoA = limits of agreement, CoV = coefficient of variation, ICC = 
intraclass correlation coefficient, CI = confidence interval, SEM = standard error of the 
measurement. 
 
Other parameters 
 
V'E/V'O2@VAT from the RATT and the cycle ergometer were comparable and both were higher 
than the treadmill. There were no significant differences in V'E/V'CO2@RCP.  The V'E-vs-V'CO2 
slope to RCP on the RATT was higher than the cycle ergometer and the treadmill (Table 1). 
V'E/V'O2@VAT, V'E/V'CO2@RCP and V'E-vs-V'CO2 slope to RCP had coefficients of variation less 
than 10%, the ICC ranged from 0.53-0.92 and the repeatability of the parameters, 
demonstrated by the mean difference, on the RATT and the treadmill were lower than the 
cycle ergometer (Table 2). 
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4. Discussion 
 
The aim of this study was to evaluate the feasibility of the RATT for estimation of 
submaximal exercise thresholds by comparison with a cycle ergometer and a treadmill. 
 
Submaximal exercise thresholds 
 
We found that V'O2@VAT and V'O2@RCP were lower on the RATT than on the cycle and the 
treadmill. These findings are in line with the differences in V'O2peak found between 3 devices: 
the V'O2peak from the RATT was approximately 20% lower than the cycle V'O2peak and 30% 
lower than the treadmill V'O2peak (Saengsuwan et al., 2015b). The lower V'O2 may be 
explained by the lower muscle mass needed to exercise on the RATT. Additionally, the 
subjects may be less familiar with the stepping movement on the RATT compared with the 
movement on the standard devices (Saengsuwan et al., 2015b).  
 
High correlations were found between V'O2@VAT and V'O2@RCP on the RATT vs the treadmill 
and on the RATT vs the cycle ergometer; however, the correlation coefficients found were 
lower than those for the V'O2peak between devices (R=0.94-0.95) (Saengsuwan et al., 2015b). 
The difference in the level of correlations found may be related to differences in muscle 
groups and muscle fibre types used during submaximal exercise on each device for each 
individual (American Thoracic Society, 2003). The correlations we found for V'O2@VAT are 
higher than in studies of arm ergometer vs cycle ergometer in normal subjects (0.60-0.64) 
(Orr et al., 2013;Loughney et al., 2014), which may reflect the closer pattern of movement 
on the RATT vs the cycle ergometer compared with different muscles used for exercise on 
the arm ergometer. 
 
We found no pairwise differences in V'O2@VAT as a percentage of V'O2peak among the three 
devices. The V'O2@VAT (%V'O2peak) found here, 49-55%, is consistent with some studies on the 
treadmill or the cycle ergometer (range from 47-58%) (Buchfuhrer et al., 1983;Nordrehaug 
et al., 1991;Habedank et al., 1998;Lucia et al., 2002;Porszasz et al., 2003;Orr et al., 2013), 
and consistent with the observation that V'O2@VAT (%V'O2peak) rarely exceeds 60% of V'O2peak 
(Meyer et al., 2005). However, other studies reported higher V'O2@VAT (%V'O2peak) (range 
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from 60.4-77%) in normal subjects (Matsumura et al., 1983;Herdy and Uhlendorf, 2011;Loe 
et al., 2014). The difference between V'O2@VAT (%V'O2peak) among studies may be caused by 
the difference in methods of identifying V'O2@VAT, the gender, the fitness level and the age 
distribution of the subjects studied. It was found that V'O2@VAT occurs at a higher percentage 
of V'O2peak in older subjects, in women and in well-trained subjects (Wasserman et al., 
1999;Green et al., 2003;Meyer et al., 2005;Itoh et al., 2013). 
 
The V'O2@RCP as a percentage of V'O2peak on the RATT was approximately 10% lower than on 
the treadmill. In general, data regarding V'O2@RCP (%V'O2peak) are less well established 
compared to V'O2@VAT (%V'O2peak). The V'O2@RCP (%V'O2peak) identified is in accordance with 
previous reports (Fontana et al., 2014;Loe et al., 2014;Oussaidene et al., 2015). The lower 
proportion of subjects whose RCP could be identified on the RATT than the cycle or the 
treadmill may reflect that the RATT is less consistent in provoking cardiorespiratory loads 
high enough to reach RCP. 
 
We found excellent test-retest reliability in submaximal exercise thresholds (ICC 0.81-0.98). 
The test-retest reliability of submaximal exercise thresholds obtained from the RATT was 
comparable to the treadmill and the cycle ergometer. The test-retest reliability for 
submaximal exercise thresholds found here were slightly lower than for peak oxygen uptake 
(ICC 0.97-0.99) (Saengsuwan et al., 2015b). The lower test-retest reliability in submaximal 
exercise thresholds than in peak oxygen uptake has been demonstrated both in normal 
subjects, and cardiac and pulmonary patients (Garrard and Emmons, 1986;Barron et al., 
2014;Myers et al., 2015). One possible explanation is that the submaximal exercise 
thresholds may be more sensitive to day-to-day biological variability (Garrard and Das, 
1987;Kothmann et al., 2009). 
 
Other parameters 
 
Although there was a trend toward higher V'E/V'CO2@RCP on the RATT, the pairwise 
comparison did not reach statistical significance. V'E/V'O2@VAT and V'E-vs-V'CO2 slope to RCP 
on the RATT were higher than on the cycle and the treadmill. A study on the arm ergometer 
found significant differences in V'E/V'O2@VAT (27.7 and 22.1) and V'E/V'CO2@VAT (29.7 and 
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25.7) between the arm ergometer and the cycle ergometer, respectively (Orr et al., 2013). 
The lower ventilatory efficiency of the RATT and arm ergometer confirms that mode 
dependency in ventilatory efficiency indices exists. Therefore, the device used for exercise 
testing should be considered in the analysis of the ventilatory efficiency data. Apart from the 
arm ergometer, there are no data regarding the ventilatory efficiency in alternative exercise 
devices for a comparison of results. Most studies on alternative devices focused more on the 
peak cardiopulmonary values (Billinger et al., 2008a;Simmelink et al., 2009) or submaximal 
values of V'O2 or heart rate (Saitoh et al., 2005;Bulthuis et al., 2010;Billinger et al., 2012). 
Since ventilatory efficiency data could provide additional information regarding the severity 
and prognosis of some heart or lung diseases (Wasserman et al., 1999;Sun et al., 2001;Arena 
et al., 2004;Myers et al., 2009), more study of these parameters on the alternative exercise 
testing devices should be done. 
 
The test-retest reliability of the ventilatory efficiency was fair to excellent. The coefficient of 
variation was less than 10%. This is consistent with Davis et al. (2006a) who found that the 
test-retest reliability of the V'E/V'CO2 and V'E-vs-V'CO2 slope to RCP were high. 
 
Our study has some limitations. Firstly, the RCP on the RATT could be identified in only 10/17 
subjects. This may be because of the limitation that the RATT can elicit lower 
cardiopulmonary responses compared to the cycle ergometer and the treadmill in healthy 
subjects. Since this device is mainly intended to be used in patients with severe disability, 
this may not be a problem in the target population. Secondly, it cannot be verified whether 
the differences in submaximal exercise thresholds on each device would be the same for 
severely disabled neurological patients because it is not possible to implement the exercise 
tests on standard devices (e.g. treadmill) in severely disabled patients.  Finally, the sample 
size was small, but the results provide preliminary estimates to support further study in 
target patient populations. 
 
5. Conclusion 
 
The results suggest that it is feasible to use the RATT for estimation of submaximal exercise 
thresholds: although V'O2@VAT and V'O2@RCP from the RATT were lower than the cycle 
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ergometer and the treadmill, there were high correlations demonstrated between the RATT 
vs the cycle ergometer and vs the treadmill; furthermore, the repeatability and test-retest 
reliability of all submaximal threshold parameters from the RATT were comparable to those 
of standard devices. There was evidence of mode-dependent differences in V'E/V'O2@VAT and 
V'E-vs-V'CO2 slope to RCP. 
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Abstract 
Background: We evaluated the feasibility of an augmented robotics-assisted tilt table (RATT) 
for incremental cardiopulmonary exercise testing (CPET) and exercise training in dependent-
ambulatory stroke patients. 
Methods: Stroke patients (Functional Ambulation Category ≤ 3) underwent familiarization, 
an incremental exercise test (IET) and a constant load test (CLT) on separate days. A RATT 
equipped with force sensors in the thigh cuffs, a work rate estimation algorithm and real-
time visual feedback to guide the exercise work rate was used. Feasibility assessment 
considered technical feasibility, patient tolerability, and cardiopulmonary responsiveness. 
Results: Eight patients (4 female) aged 58.3 ± 9.2 years (mean ± SD) were recruited and all 
completed the study. For IETs, peak oxygen uptake (V'O2peak), peak heart rate (HRpeak) and 
peak work rate (WRpeak) were 11.9 ± 4.0 ml/kg/min (45 % of predicted V'O2max), 117 ± 32 
beats/min (72 % of predicted HRmax) and 22.5 ± 13.0 W, respectively. Peak ratings of 
perceived exertion (RPE) were on the range "hard" to "very hard". All 8 patients reached 
their limit of functional capacity in terms of either their cardiopulmonary or neuromuscular 
performance.  
A ventilatory threshold (VT) was identified in 7 patients and a respiratory compensation 
point (RCP) in 6 patients: mean V'O2 at VT and RCP was 8.9 and 10.7 ml/kg/min, respectively, 
which represent 75 % (VT) and 85 % (RCP) of mean V'O2peak. Incremental CPET provided 
sufficient information to satisfy the responsiveness criteria and identification of key 
outcomes in all 8 patients. 
For CLTs, mean steady-state V'O2 was 6.9 ml/kg/min (49 % of V'O2 reserve), mean HR was 90 
beats/min (56 % of HRmax), RPEs were > 2, and all patients maintained the active work rate 
for 10 min: these values meet recommended intensity levels for bouts of training. 
Conclusions: The augmented RATT is deemed feasible for incremental cardiopulmonary 
exercise testing and exercise training in dependent-ambulatory stroke patients: the 
approach was found to be technically implementable, acceptable to the patients, and it 
showed substantial cardiopulmonary responsiveness. This work has clinical implications for 
patients with severe disability who otherwise are not able to be tested.  
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1. Background 
 
Cardiopulmonary fitness is compromised in stroke patients: their peak oxygen uptake 
(V'O2peak) ranges from 8-22 mL/kg/min, which corresponds to approximately half of age and 
gender matched healthy controls (Kelly et al., 2003;Smith et al., 2012). The low V'O2peak limits 
patients' ability to live independently (Shephard, 2009) and hinders participation in 
rehabilitation and exercise programmes (Billinger et al., 2014). Low cardiopulmonary fitness 
can further heighten the existing risk for cardiovascular disease (Bijnen et al., 1994) by 
predisposing patients to a sedentary lifestyle because of activity limitation and early fatigue 
(Tseng and Kluding, 2009).  
A recent joint statement from the American Heart Association and the American Stroke 
Association recommends that stroke patients should undergo cardiopulmonary exercise 
testing (CPET) (Billinger et al., 2014). CPET delivers objective measures which allow accurate 
quantification of cardiorespiratory fitness, delineation of the physiological systems 
underlying exercise responses, and identification of exercise-limiting pathophysiological 
mechanisms (Guazzi et al., 2012). CPET outcomes can also be used to evaluate the effects of 
a longitudinal training programme and to determine the training intensity for individualized 
exercise prescription (Myers and Nieman, 2010;Marzolini et al., 2012;Billinger et al., 2014). 
However, impairments following stroke such as weakness, ataxia or spasticity can preclude 
some patients from exercise testing on standard devices. Semi-recumbent cycle ergometers 
and total-body recumbent steppers have hitherto been used as alternatives to standard 
treadmills and cycle ergometers in order to test patients with balance and coordination 
problems (Billinger et al., 2014). 
Despite increasing availability of adapted devices, suitable methods and data for patients 
who are severely disabled are lacking. This problem is clearly demonstrated in the systematic 
review by Smith et al. (2012), where only 2 of the 42 studies included reported data from 
dependent-ambulatory patients. The authors pointed out that the exclusion of the severely 
disabled group may result in overestimation of cardiopulmonary fitness for the entire stroke 
population (Smith et al., 2012). Another systematic review on the effects of cardiovascular 
exercise early after stroke pointed out that concepts to influence and evaluate 
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cardiopulmonary fitness in severely disabled patients are still lacking (Stoller et al., 2012). 
These open questions are addressed in the present work. 
A robotics-assisted tilt table (RATT) is a device used clinically for early rehabilitation in 
severely impaired and bedridden neurological patients. It tilts the patient upright, provides 
support with a body harness, promotes weight bearing on the feet and moves the legs in a 
cyclic stepping movement. To promote active participation during the rehabilitation process, 
we have augmented a RATT system to allow patients to see their exercise work rate together 
with a target work rate (Bichsel et al., 2011). This approach was shown to be feasible for 
exercise testing both in normal subjects and in spinal cord injured patients (Saengsuwan et 
al., 2014;Laubacher et al., 2015). We hypothesized that the augmented RATT should enable 
stroke patients with severe motor weakness to be tested. 
Incremental CPET aims to approach a person's limit of functional capacity in regard to 
cardiopulmonary and/or neuromuscular exertion. The main parameters investigated here, 
which can be determined from incremental CPET, include both peak and submaximal values:  
• Peak: peak oxygen uptake (V'O2peak), which represents aerobic capacity; peak heart 
rate (HRpeak); and peak work rate (WRpeak), which is the highest volitional effort. 
Additional criteria are applied to V'O2 and WR responses to determine whether the 
observed peaks represent true maximal values. 
• Submaximal: the 1st ventilatory threshold, denoted here as VT, which provides an 
approximation of endurance capacity (Wasserman et al., 1999;Guazzi et al., 2012); 
and the 2nd ventilatory threshold, denoted here as the respiratory compensation 
point (RCP), that occurs at the onset of hyperventilation (Meyer et al., 2004). 
• Subjective measures such as rating of perceived exertion (RPE) may also be recorded 
at intervals throughout the test. 
This is the first study where the novel augmented RATT system was applied to severely-
disabled patients. Therefore we wanted to investigate whether, with this new exercise 
testing modality, the principal incremental CPET outcomes can be identified and whether, 
during constant-load CPET, sustained exercise intensity meets recommendations for 
training.  
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The aim of this study was therefore to evaluate the feasibility of the augmented RATT for 
incremental cardiopulmonary exercise testing and exercise training in dependent-
ambulatory stroke patients, i.e. those with severe physical disability who are unable to use 
standard devices. Criteria for the feasibility assessment were: (i) implementation – technical 
feasibility of the augmented RATT for exercise testing, (ii) acceptability – was the exercise 
tolerable?, and (iii) responsiveness – was there a measurable, high-level cardiopulmonary 
reaction? 
 
2. Materials and methods 
 
Study design and participants 
This descriptive, cross-sectional feasibility study was conducted at the Reha Rheinfelden, a 
rehabilitation centre in the north-west of Switzerland, from October 2013 to April 2014. The 
Ethics Review Committee of Canton Aargau, Switzerland, approved the study. All subjects 
gave their written informed consent before participating in the study.  
 
Eight patients (4 female) aged 58.3 ± 9.2 years (mean ± SD) were recruited and all completed 
the study. The mean Functional Ambulation Category (FAC) was 1.8 (range 0-3; Table 1) 
(Holden et al., 1984). Patient inclusion criteria were: (1) a diagnosis of first-ever stroke, 
either ischaemic or intracerebral haemorrhage by radiologic evidence; (2) > 2 months post 
stroke; (3) > 18 years old; (4) dependent in ambulation with Functional Ambulation Category 
(FAC) ≤ 3; (5) Mini Mental State Examination (MMSE) score > 20 (cognitive function) (Folstein 
et al., 1975); and (6) willing to cooperate in the study and able to attend all testing sessions. 
Exclusion criteria were: (1) any contraindications to maximal exercise testing according to 
the American College of Sports Medicine guidelines (Pescatello et al., 2014); (2) any 
contraindications for the RATT based on guidelines from the manufacturer; (3) severe 
aphasia or other communication problems; and (4) severe concurrent pulmonary disease. A 
cardiologist reviewed all prospective subjects for cardiac status before giving approval for 
formal enrolment. 
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Table 1. Characteristics and demographic data of subjects (n=8). 
Characteristic Value 
Age (years) 58.3 ± 9.2 
Sex, n (%) 
Male 
Female  
 
4 (50%) 
4 (50%) 
Height (cm) 167.6 ± 8.8 
Body mass (kg) 75.2 ± 7.4 
Body mass index (kg/m2) 26.9 ± 3.3 
Type of stroke, n (%) 
Ischaemic 
Haemorrhagic 
 
5 (62.5%) 
3 (37.5%) 
Hemiparetic side, n (%)  
Left 
Right 
Bilateral 
 
4 (50%) 
3 (37.5%) 
1 (12.5%) 
Years post stroke, median (IQR) 1 y 42 d (8.2 y) 
FAC, mean (range) 1.8 (0-3) 
MMSE score 27.1 ± 3.2 
Comorbidities, n (%)  
Diabetes mellitus  
Hypertension 
Dyslipidemia 
None 
 
1 (12.5%) 
5 (62.5%) 
2 (25%) 
3 (37.5%) 
Antihypertensive Medications, n (%) 
β-blocker 
ACE inhibitors  
Calcium channel blockers 
None 
 
1 (12.5%) 
3 (37.5%) 
1 (12.5%) 
3 (37.5%) 
Values are mean ± SD unless otherwise indicated. 
Abbreviations: n, number; SD, standard deviation; MMSE, Mini Mental State Examination; 
IQR, Interquartile range; FAC, Functional Ambulation Category; ACE, angiotensin-converting-
enzyme. 
 
Robotics-assisted tilt table (RATT) 
A RATT system (Erigo, Hocoma AG, Switzerland) was augmented to facilitate active 
participation during exercise. The basic RATT is a motorized tilt table with a body harness to 
support the body and two motor drives to support cyclical movement of the legs. Two thigh 
cuffs fix the legs and interface to the leg drives, and two foot plates support the feet.  The 
RATT is designed to be used for early rehabilitation in neurological patients to provide early 
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mobilization and intensive sensorimotor stimulation. Additionally, it is also claimed to 
enhance cardiovascular output by cyclic leg loading. During the therapy, the RATT can be 
tilted up from 0 to 80 degrees and the cyclic leg movement can be set to a stepping cadence 
between 8 and 80 steps/min. 
With the augmented RATT system, patients are able to see their exercise work rate together 
with a target work rate (Bichsel et al., 2011). This was achieved by adding individual force 
sensors to the left and right leg cuffs, a work rate estimation algorithm and a real time visual 
feedback system (Figure 1). Patients were instructed to adapt their volitional leg effort to 
follow the target. Active exercise is achieved by producing forces into the leg cuffs in 
synchrony with the movement of the RATT. 
Experimental procedures 
Patients took part in three exercise sessions, each separated by a minimum of 24 hours: a 
familiarization, an incremental exercise test (IET), and a constant load test (CLT). Patients 
were instructed to avoid strenuous activity within the 24 hours before the test sessions and 
not to consume a large meal, caffeine or nicotine in the three hours prior to testing (Pina et 
al., 1995). 
 
For each test, the patient was first transferred and secured to the RATT in accordance with 
the manufacturer's guidelines. Then the additional measurement systems (i.e. automatic 
blood pressure monitoring, and mask for breath-by-breath gas analysis) were fitted. The 
patient was then tilted upwards to 60 degrees. During the test, the stepping cadence was set 
at 80 steps/min. 
The familiarization was to instruct patients regarding the RATT, the measurement systems 
and the test procedures. It included a short ramp phase of 5-min duration and work rate 
ramp of 3 W/min to allow estimation of an appropriate ramp rate for the subsequent IET. 
The IET consisted of: (1) a recorded rest phase, where the patient lay passively on the RATT 
for 3 min; (2) a passive phase, where the RATT moved the patient's legs for 5 min; (3) a ramp 
phase, where the patients actively moved their legs in synchrony with the RATT motion 
while attempting to follow the linearly increasing work rate target. The work rate ramp was 
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set individually in the range of 1.2 to 3.5 W/min based on observations from the ramp phase 
of the familiarization with the aim to bring the patient to their functional limit within 8-12 
min; and (4) a recovery phase, similar to the initial passive phase, where the RATT moved the 
patient's legs for 5 min. The termination criteria for the ramp phase followed the American 
College of Sports Medicine guidelines (Pescatello et al., 2014). Additionally, blood pressure 
(BP) was used as a termination criterion: systolic BP > 210 mmHg or diastolic BP > 115 mmHg 
(Tang et al., 2006). 
The CLT consisted of: (1) a rest phase for 3 min; (2) a passive phase for 5 min; (3) a constant 
load phase, where the patient actively moved their legs in synchrony with the RATT motion 
to follow the constant target work rate (the work rate was set at 40% of peak work rate 
(WRpeak) obtained from the IET) for 10 min; and (4) a recovery phase for 5 min.  
 
 
 
 
 
 
 
 
 
 
 
Figure 1. A modified robotics-assisted tilt table (RATT) with force sensors under the thigh 
cuffs, visual feedback system and breath-by-breath cardiopulmonary monitoring system. 
 
Outcome measures 
Metabolic gas exchange was recorded using a breath-by-breath system (MetaMax 3B, Cortex 
Biophysik GmbH, Germany) and outcome variables were analysed using the associated 
Metasoft software. Prior to each test, pressure, volume and gas calibration were performed: 
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volume was calibrated using a 3-L syringe and gas was calibrated using ambient air and a 
certified precision gas mixture (15% oxygen and 5% carbon dioxide) according to the 
manufacturer's instructions. Heart rate was continuously recorded using a chest strap 
(model T34, Polar Electro Oy, Finland). Blood pressure was measured by automatic 
sphygmomanometry (HEM 907XL, Omron Corporation, USA) every 2 min during the tests.  
 
Outcome measures for IETs were as follows. Peak oxygen uptake (V'O2peak) was determined 
as the maximum of a 30-s average during the ramp phase. The peak respiratory exchange 
ratio (RERpeak) was the 30-s average of RER at the time of V'O2peak. Peak heart rate (HRpeak) 
was defined as the highest value of HR reached during the ramp phase. The peak work rate 
(WRpeak) was calculated as the maximum of a 10-second moving average of the recorded 
work rate.  
 
The first and second ventilatory thresholds (VT and RCP) were determined independently by 
two experienced raters (JSa and KH) using the methods described by Binder et al. (2008) and 
summarised in the following paragraphs, and the average of the two ratings was taken. The 
thresholds were characterized by the value of V'O2 at the point where the criteria given 
below were deemed to be fulfilled. Threshold analysis was carried out visually based on  
15-breath averages of the variables concerned. 
 
The first ventilatory threshold, i.e. that which is denoted here as the VT, was determined 
graphically using the combination of these criteria: (1) the point at which the ventilatory 
equivalent for oxygen (V'E/V'O2) reaches a minimum or has its first increase without a 
simultaneous increase in the ventilatory equivalent for carbon dioxide (V'E/V'CO2); (2) the 
point at which partial pressure of end-tidal oxygen tension (PETO2) reaches a minimum or has 
its first increase without a decrease in the partial pressure of end-tidal carbon dioxide 
tension (PETCO2); and, (3) the deflection point of carbon dioxide output (V'CO2) versus 
oxygen uptake (V'O2; V-slope method). When these 3 criteria gave different results, the first 
two were prioritized. 
 
The second ventilatory threshold, i.e. the respiratory compensation point (RCP), was 
determined graphically by inspection of: (1) the minimal value or nonlinear increase of 
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V'E/V'CO2; (2) the turning point of PETCO2; and, (3) the point of deflection of minute 
ventilation (V'E) versus V'CO2 (Binder et al., 2008). Again, if these 3 criteria gave different 
results, the first two were prioritized.  
 
Borg CR10 ratings of perceived exertion (RPE) for dyspnea and leg effort (Borg, 1982) were 
recorded every 3 min during the tests. The reasons for test termination were recorded. 
 
Outcome measures for CLTs were the steady-state V'O2 and heart rate during the rest, 
passive and constant load phases. The accuracy of the patient's achievement of target work 
rate was quantified by the root mean square error (RMSE) between the target and actual 
work rates between the first and ninth min of the constant load phase. The Borg CR10 RPE 
ratings for dyspnea and leg effort were recorded.  
 
Criteria to determine feasibility of the RATT for exercise testing and training 
The criteria for feasibility assessment were (Bowen et al., 2009): (i) implementation 
(technical feasibility of the augmented RATT for exercise testing), (ii) acceptability (was the 
exercise tolerable?), and (iii) responsiveness (was there a measurable, high-level 
cardiopulmonary reaction?).  
 
Incremental CPET was considered to have satisfied responsiveness criteria if in a given 
patient at least one of the following outcomes could be identified from the IETs (adapted 
from Marzolini et al. (2012): V'O2max, WRmax, VT or RCP.  
The first two of these, V'O2max and WRmax, indicate whether a patient's functional capacity in 
terms of cardiopulmonary and/or neuromuscular exertion was reached: 
• V'O2max was deemed to have been achieved if at least one of the following was 
observed: plateau in V'O2 (increase in V'O2 less than 150 mL in the final minute of 
exercise (MacKay-Lyons and Makrides, 2002)), RER ≥ 1.10 (or RER ≥ 1.05 for age ≥ 50 
(Edvardsen et al., 2014) or HRpeak ≥ HRmax – 10 (Marzolini et al., 2012). Here, HRmax 
was obtained from an age-related prediction formula (Pescatello et al., 2014). 
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• Achievement of WRmax was marked by a plateau in WR with the patient no longer 
able to reach the WR target. 
 
Constant-load CPET was considered to have satisfied responsiveness criteria if the intensity 
and duration of steady-state exercise during CLTs was found to have met current 
recommendations for exercise and physical activity after stroke; these are defined as 40% to 
70% of V'O2 reserve or HR reserve; or, 55% to 80% of HRmax; or, RPE of 11 to 14 on the Borg 
scale (6-20) (Billinger et al., 2014). V'O2 reserve is defined as V'O2peak – V'O2rest and HR 
reserve as HRpeak – HRrest (Pescatello et al., 2014). 
 
Statistical analysis 
Descriptive statistics were used to evaluate the distribution of the variables. Continuous 
variables are presented as mean ± standard deviation. Categorical variables are presented as 
frequencies and percentages. All analyses were performed using SPSS version 19 (IBM 
Corporation, USA). 
 
3. Results 
 
(i) Implementation: The augmented RATT could be successfully used to implement both the 
IET and the CLT in stroke patients without the need to further modify the system. There 
were no technical problems that interrupted the tests. 
(ii) Acceptability: The patients could understand the task to keep up with the work rate 
target using the visual feedback system and adaptation of their volitional leg effort. All 
patients could exercise until the end of the protocols without any complications. All tests 
were completed successfully according to the termination criteria (IET) or pre-specified 
duration (CLT). 
(iii) Responsiveness: IET (n = 8; Table 2): Absolute V'O2peak was 845 ± 266 mL/min (relative 
V'O2peak was 11.9 ± 4.0 mL/kg/min), which corresponds to 45.2% of the expected V'O2max 
based on the prediction method of Wasserman et al. (1999). HRpeak was 117 ± 32 beats/min, 
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which is 72.0% of the predicted value (Table 2). WRpeak was 22.5 ± 13.0 W. The average 
ratings of perceived exertion (RPE, Borg CR10) for dyspnea and leg effort at the end of the 
ramp phase were 5.4 and 6.6, respectively; these lie on the qualitative range of "hard" to 
"very hard". 
Reasons for termination of the IET were: leg fatigue (n = 4, 50%); abnormal blood pressure, 
i.e. systolic BP > 210 mmHg, (n = 2, 25%); breathing effort (n = 1, 12.5%); and generalized 
fatigue (n = 1, 12.5%).  
The VT was identified in 7 patients (4 female) and the RCP in 6 patients (3 female). The 
average absolute V'O2 values at VT and RCP were 677 and 800 mL/min (relative V'O2 at VT 
and RCP was 8.9 and 10.7 mL/kg/min) which represent 75.1% (VT) and 84.8% (RCP) of mean 
V'O2peak. 
Incremental CPET provided sufficient information to satisfy the responsiveness criteria, i.e. 
V'O2max, WRmax, VT or RCP were able to be determined, in all 8 patients (4 female, 4 male): all 
8 patients reached the limit of functional capacity in terms of either V'O2max (7 patients – 4 
female) or WRmax (6 patients – 3 female). Of the 7 patients deemed to have satisfied the 
criteria for V'O2max, 5 reached a plateau, 3 met the RER criterion and 1 met the HRmax 
criterion. 
To illustrate typical IET responses, Figure 2 shows the target and measured work rates as 
well as cardiopulmonary responses from the IET in Patient 8. Figure 3 shows the graphical 
plots for determination of the VT and the RCP in the same patient. 
CLT (n = 8; Table 3): The transition from passive to constant load exercise yielded a higher 
increase in V'O2 (2.7 mL/kg/min) than did the transition from rest to passive (0.9 mL/kg/min) 
(Table 3). During the active phase of the exercise, all patients were able to achieve the 
recommended training intensity level (Billinger et al., 2014) based on percentage of V'O2 
reserve, percentage of HRmax, and RPE: the constant work rate was set at 40% of individual 
WRpeak values which resulted, on average, in a steady-state V'O2 of 49 % of V'O2 reserve, 
steady-state HR of 56 % of predicted HRmax and RPE > 2. All patients could maintain the 
active work rate for 10 min as prescribed. The accuracy of maintaining the work rate target 
(RMSE) was 1.3 W. 
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Figure 2. Typical peak cardiopulmonary responses (Subject 8) during the IET test protocol. (a) Target 
and measured work rates, (b) respiratory exchange ratio (RER), (c) oxygen uptake (V'O2) and carbon 
dioxide output (V'CO2), (d) heart rate (HR). The plots of RER, V'O2, V'CO2 and HR show averages over 
a 30s moving window. 
 
Figure 3. Determination of the 1st ventilatory threshold (VT) and the respiratory compensation point 
(RCP) from Subject 8. (a) VT is at the minimal value of PETO2 and RCP at the turning point of PETCO2, 
(b) VT is at the minimal value of V'E/V'O2 and RCP at the minimal value of V'E/V'CO2, (c) VT is at the 
deflection point of V'CO2 vs. V'O2 ('V-slope method'), (d) RCP is at the deflection point of V'E vs. 
V'CO2. 
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Table 2. Summary of outcome variables from incremental exercise tests (n=8). 
 
Outcome Variable Value  Range 
Peak Exercise Variables   
  V'O2peak absolute (mL/min) 844.8 ± 265.7 352.0 – 1176.0 
  V'O2peak relative (mL/min/kg) 11.9 ± 4.0 5.6 – 17.5 
V'O2peak as % of predicted V'O2max 
(Wasserman et al., 1999) 
45.2 ± 8.8 32.3 – 58.2 
HRpeak (beats/min) 117.3 ± 31.5 66.0 – 155.0 
HRpeak as % of predicted HRpeak (220-age) 72.0 ± 17.7 44.9 – 99.3 
SBP (mmHg) 192.9 ± 29.9 140.0 – 220.0 
DBP (mmHg) 88.5 ± 12.7 78.0 – 110.0 
Rate-pressure product  230.0 ± 79.8 92.4 – 341.0 
RERpeak 1.00 ± 0.10 0.78 – 1.20 
Borg CR10 RPE scale dyspnea 5.4 ± 2.8 1.0 – 9.0 
Borg CR10 RPE scale leg effort 6.6 ± 1.9 4.0 – 9.0 
Oxygen cost of work (mL/min/W) (n=6) 21.9 ± 3.8 16.0-26.0 
WRpeak (W) 22.5 ± 13.0 5.5 – 38.6 
Time to V'O2peak (sec) 742.5 ± 161.8 600.0 – 1080.0 
 Submaximal Exercise Variables (n=7)   
Absolute V'O2 at VT (mL/min) 677.1 ± 187.1 520.0 – 1053.0 
Relative V'O2 at VT (mL/kg/min) 8.9 ± 2.9 6.9 – 15.0  
VT as % of V'O2peak 75.1 ± 17.6 52.3 – 100.8  
RER at VT 0.88 ± 0.08 0.78 – 0.96 
Absolute V'O2 at RCP (mL/min) (n=6) 800.3 ± 206.7 547.0 – 1136.0 
Relative V'O2 at RCP (mL/kg/min) (n=6)  10.7 ± 3.1 7.3 – 16.2 
RCP as % of V'O2peak (n=6) 84.8 ± 11.6 70.6 – 99.3 
RER at RCP (n=6) 1.02 ± 0.13 0.84 – 1.24 
Values are mean ± SD. 
Abbreviations: V'O2peak, peak oxygen uptake; V'O2, oxygen uptake; HR, heart rate; HRpeak, 
peak heart rate; RERpeak, peak respiratory exchange ratio; SBP, systolic blood pressure; DBP, 
diastolic blood pressure; RPE, rating of perceived exertion; WRpeak, peak work rate; VT, 1st 
ventilatory threshold; RER, respiratory exchange ratio; RCP, respiratory compensation point. 
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Table 3. Summary of outcome variables from constant load tests (n=8). 
 
Outcome Variables Values 
Initial Rest Phase  
 V'O2 absolute (mL/min) 243.9 ± 33.6 
 V'O2 relative (mL/min/kg) 3.30 ± 0.43 
HR (beats/min) 73.8 ± 9.8 
 Passive Phase  
 V'O2 absolute (mL/min) 316.6 ± 75.9 
 V'O2 relative (mL/min/kg) 4.20 ± 0.78 
HR (beats/min) 76.3 ± 10.0 
Constant Load Phase  
 V'O2 absolute (mL/min) 519.5 ± 117.7 
 V'O2 relative (mL/min/kg) 6.9 ± 1.6 
 V'O2 as % of V'O2 reserve 48.7 ± 19.1 
HR (beats/min) 90.3 ± 18.6 
HR as % of HR reserve 34.8 ± 32.0 
HR as % of HRmax 56.0 ± 9.9 
WR (W) 11.5 ± 6.1 
Borg CR10 RPE scale dyspnea 2.1 ± 1.0 
Borg CR10 RPE scale leg effort 2.9 ± 0.6 
 RMSE of WR (W) 1.3 ± 1.0 
Values are mean ± SD. 
Abbreviations: V'O2, oxygen uptake; HR, heart rate; WR, work rate; W, Watts; RPE, rating of 
perceived exertion; RMSE, root mean square error.  
 
4. Discussion 
 
The aim of this study was to evaluate the feasibility of the augmented RATT for incremental 
cardiopulmonary exercise testing and exercise training in dependent-ambulatory stroke 
patients. Feasibility assessment considered technical feasibility, patient tolerability, and 
cardiopulmonary responsiveness. 
Feasibility for incremental cardiopulmonary exercise testing 
For all 8 patients tested, incremental CPET provided sufficient information to satisfy the 
responsiveness criteria, i.e. V'O2max, WRmax, VT or RCP were successfully identified. All 8 
patients also reached their limit of functional capacity due to either cardiopulmonary 
limitations (V'O2max criteria; 7 patients – 4 female) or neuromuscular limitations (WRmax 
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criteria; 6 patients – 3 female). Of these 8 patients, 5 reached both sets of criteria for 
cardiopulmonary and neuromuscular capacity, 2 patients satisfied only the cardiopulmonary 
criteria, and 1 patient reached only the neuromuscular limitation. 
It is interesting that, in these numbers, female patients are at least as highly represented as 
males. Marzolini et al. (2012) previously noted that females after stroke were much less 
likely than males to achieve similar feasibility criteria from baseline CPETs: 40% for females 
vs. 81% for males. That difference was attributed to greater disability and weakness in the 
females examined in a study of mildly-impaired patients. The results herein, with severely-
impaired patients, indicate that such measurement difficulties can be overcome by 
employing appropriate testing equipment, i.e. the augmented RATT. However, more 
subjects are required to reliably study these male-female ratios in the outcomes. 
The V'O2peak reported in this study (11.9 ± 4.0 mL/kg/min) is lower than values previously 
reported in ambulatory stroke patients using: cycle ergometry, 17.2 ± 3.0 mL/kg/min (Eng et 
al., 2004); recumbent cycle ergometry, 16.0 ± 1.2 mL/kg/min (Tomczak et al., 2008); or a 
treadmill with body weight support, 14.4 ± 5.1 mL/kg/min (MacKay-Lyons and Makrides, 
2002). This low value may be attributable in part to the more profound disability in the 
patients in the present study and in part to the observation that, in normal subjects, the 
RATT V'O2peak is approximately 20% lower than with a cycle ergometer and 30% lower than 
for a treadmill (Saengsuwan et al., 2015b). 
HRpeak was on average 72 % of the predicted value. The rate-pressure product, which reflects 
the cardiovascular load during exercise, was 230. These results are comparable to previously 
documented results in mildly to moderately disabled stroke patients (MacKay-Lyons and 
Makrides, 2002;Kelly et al., 2003;Eng et al., 2004;Hyun et al., 2015). This suggests a similar 
myocardial work load. 
Successful identification of a VT (7 patients – 4 female) and/or an RCP (6 patients – 3 female) 
from incremental CPET provides an additional means of prescribing exercise intensity. The 
relative V'O2peak at the VT (8.9 mL/kg/min) is lower than previous reports (Tang et al., 
2006;Marzolini et al., 2012), which may be due to the same reasons as described above in 
relation to lower V'O2peak. The VT as a percentage of V'O2peak found in this study is in line with 
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other studies which reported values in the range 73.4 to 89.7% of V'O2peak (Tang et al., 
2006;Chen et al., 2010;Marzolini et al., 2012). 
Feasibility for exercise training 
Current standards for prescription of exercise intensity for stroke patients are derived from a 
subset of the main incremental CPET outcomes. For stroke patients, these are (Billinger et 
al., 2014): 40 % to 70 % of V'O2 reserve or HR reserve; or, 55 % to 80 % of maximal HR; or, 
RPE between 11 and 14 (6 to 20 scale), which corresponds approximately to 2 to 4.5 on the 
Borg CR10 RPE scale. It is recommended that this intensity level should be reached on 3 to 5 
days per week using 20 to 60 min per exercise session or by multiple 10-min sessions. 
The CLTs demonstrate that, during the active phase of the exercise, all patients were able to 
sustain the recommended intensity level based on percentage of V'O2 reserve, percentage of 
HRmax, and RPE for 10 min: the constant work rate was set at 40% of individual WRpeak values 
which resulted, on average, in a steady-state V'O2 of 49 % of V'O2 reserve, steady-state HR of 
56 % of HRmax and RPE > 2. 
During the passive phases of the CLTs the exercise intensity was far below the recommended 
levels: passive V'O2 was on average 18 % of V'O2 reserve and passive HR was 9 % of HR 
reserve. This demonstrates that muscle activation is very low during passive movement and 
emphasises the need for active participation of the patient using the work rate biofeedback 
screen implemented within the augmented RATT. This low intensity of passive motion 
confirms a previous report with robotics-assisted treadmill exercise (Jack et al., 2011). With 
this low intensity, patients cannot effectively improve their cardiopulmonary fitness. 
These considerations show that the augmented RATT is a feasible platform for 
implementation of a prescribed exercise training programme where 10-min bouts of 
exercise form part of the recommendations, but future work is required to investigate the 
response to a longitudinal training intervention using the RATT. 
Limitations 
The RATT V'O2peak was previously observed to be approximately 20% lower than the cycle 
ergometer and 30% lower than the treadmill in normal subjects (Saengsuwan et al., 2015b), 
but it is not certain whether these differences would be the same in stroke patients. Further 
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study is needed to address the comparability of the RATT and the standard exercise testing 
devices (e.g. cycle ergometer) in patients who are capable of using conventional modalities. 
It was observed here that the efficiency of work production on the RATT, as characterized by 
the inverse of the oxygen cost of the work (mean value 21.9 mL/min/W, Table 2), is 
substantially lower than for cycle or treadmill ergometry. This was also observed previously 
in able-bodied subjects on the RATT (Saengsuwan et al., 2014). This is probably due to a 
combination of factors including the way the muscle groups are activated and the 
employment of a possibly non-optimal exercise cadence. Here, a cadence of 80 steps/min 
was used as this is the highest rate allowed by the device employed. To improve efficiency, a 
higher stepping rate might be desirable, so that lower forces are needed for a given work 
rate target (because work rate is the product of torque and angular velocity). 
The small sample size in this study may limit generalizability of the data describing 
cardiopulmonary fitness in dependent-ambulatory stroke patients. The V'O2peak in this study 
may still be an overestimate in relation to the overall population because we did not include 
patients who had heart disease or who were not approved by the cardiologist for cardiac 
safety. Additionally, the mean age of the patients (58.3 years) was slightly lower than the 
general stroke population reported in high income countries (66 years) (O'Donnell et al., 
2010) or in Switzerland (72.5 years) (Michel et al., 2010).  
 
5. Conclusion 
 
The augmented RATT is deemed feasible for incremental cardiopulmonary exercise testing 
and exercise training in dependent-ambulatory stroke patients: the approach was found to 
be technically implementable, it was well tolerated by the patients (acceptability), and 
substantial cardiopulmonary responses were observed (responsiveness). 
 
Abbreviations 
CPET: cardiopulmonary exercise testing; CLT: constant load test; HR: heart rate; HRpeak: peak 
heart rate; HRmax: maximal heart rate; IET: incremental exercise test; PETCO2: partial pressure 
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of end-tidal carbon dioxide tension; PETO2:  partial pressure of end-tidal oxygen tension; 
RATT: robotics-assisted tilt table; RCP: respiratory compensation point; RERpeak: peak 
respiratory exchange ratio; RMSE: root mean square error; RPE, rating of perceived exertion; 
V'CO2: carbon dioxide output; V'E: minute ventilation; V'O2: oxygen uptake; V'O2max: maximal 
oxygen uptake; V'O2peak: peak oxygen uptake; VT: ventilatory threshold; WRpeak: peak work 
rate.  
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Abstract 
Background: Exercise testing devices for evaluating cardiopulmonary fitness in patients with 
severe disability after stroke are lacking. We have adapted a robotics-assisted tilt table 
(RATT), which is used clinically for early neurorehabilitation, for cardiopulmonary exercise 
testing (CPET). Using the RATT in a sample of patients after stroke, this study aimed to 
investigate test-retest reliability and repeatability of CPET and to prospectively study 
changes in cardiopulmonary outcomes over a period of four weeks. 
Methods: Stroke patients with all degrees of disability underwent 3 separate CPET sessions: 
2 tests at baseline (TB1 and TB2) and 1 test at follow up (TF). TB1 and TB2 were at least 24 
hours apart. TB2 and TF were 4 weeks apart.  A RATT equipped with force sensors in the 
thigh cuffs, a work rate estimation algorithm and a real-time visual feedback system was 
used to guide the patients' exercise work rate during CPET. Test-retest reliability and 
repeatability of CPET variables were analysed using paired t-tests, the intraclass correlation 
coefficient (ICC), the coefficient of variation (CoV), and Bland and Altman limits of 
agreement. Changes in cardiopulmonary fitness during four weeks were analysed using 
paired t-tests. 
Results: Seventeen sub-acute and chronic stroke patients (age 62.7 ± 10.4 years [mean ± 
SD]; 9 females) completed the test sessions. For test-retest, there were no statistically 
significant differences between TB1 and TB2 for most CPET variables. Absolute peak oxygen 
uptake, relative peak oxygen uptake, peak heart rate, peak work rate and oxygen uptake at 
the ventilatory anaerobic threshold and respiratory compensation point showed good to 
excellent test-retest reliability (ICC 0.65-0.94). For all CPET variables, CoV was 4.1-14.5%.  
The mean difference was close to zero in most of the CPET variables. There was no 
significant difference in most cardiopulmonary performance parameters during the 4-week 
period (TB2 vs TF). 
Conclusions: These findings provide the first evidence of test-retest reliability and 
repeatability of the principal CPET variables using the novel RATT system and testing 
methodology. Good to excellent test-retest reliability and repeatability were found for all 
submaximal and maximal CPET variables. Reliability and repeatability of the main CPET 
parameters in stroke patients on the RATT were comparable to previous findings in stroke 
patients using standard exercise testing devices. There were no significant changes in most 
CPET outcomes over a period of four weeks. 
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1. Introduction 
 
Stroke is one of the leading causes of adult disability worldwide (Adamson et al., 
2004;Mozaffarian et al., 2015). Stroke affects not only the neurological system but also 
affects pulmonary and cardiovascular health (Teasell, 1992;Billinger et al., 2012). The effect 
of stroke on the cardiovascular system can result from: existing comorbid conditions, e.g. 
coronary artery disease; a direct effect of stroke on impairments in cardiovascular 
regulation; or, an indirect effect from weakness, fatigue or spasticity that leads to a 
sedentary lifestyle and results in a further decline in cardiopulmonary fitness (Myers and 
Nieman, 2010;Billinger et al., 2012). 
Cardiopulmonary exercise testing (CPET) is important to determine a patient’s 
cardiopulmonary fitness and to accurately prescribe an individualised exercise programme 
(Billinger et al., 2014). The most commonly used devices, i.e. a treadmill or a cycle 
ergometer, cannot be used in all stroke patients – their use is limited to mildly or moderately 
impaired stroke patients (Smith et al., 2012). Systematic reviews showed that suitable 
methods to measure cardiopulmonary fitness and to provide appropriate exercise in stroke 
patients with severe disability are still lacking (Stoller et al., 2012;Marsden et al., 2013). This 
problem needs to be addressed early because stroke incidence is projected to increase as a 
result of a higher proportion of older people in the population in the future (Truelsen et al., 
2006) and because people who live with disability after stroke have a longer survival than 
formerly (Boysen et al., 2009). 
A robotics-assisted tilt table (RATT), which is used clinically for early neurorehabilitation, was 
adapted for CPET in this study. This device was considered to have potential to be used in 
severely disabled patients because it has a harness to provide body support and it 
incorporates thigh cuffs and footplates to secure the legs. As the patient is well supported, 
the risk of falls or exercise related injuries is likely lower than a treadmill. The RATT was 
augmented with force sensors, a work rate calculation algorithm and a visual feedback 
system to facilitate exercise testing and training (Bichsel et al., 2011). A previous validity and 
reliability study in normal subjects found that peak oxygen uptake and submaximal exercise 
thresholds on the RATT were approximately 20% lower than for a cycle ergometer. Test-
retest reliability of maximal and submaximal exercise thresholds on the RATT were 
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comparable to standard exercise devices (Saengsuwan et al., 2015b;c). Furthermore, a 
feasibility study in non-ambulatory stroke patients showed that stroke patients with severe 
disability could successfully undergo CPET and exercise training on the RATT (Saengsuwan et 
al., 2015a). 
Test-retest reliability of peak and submaximal cardiopulmonary exercise parameters, which 
are normally used as the main outcomes for exercise intervention studies, require careful 
analysis prior to future clinical uptake of the RATT. Although reliability data in normal 
subjects have been established, this form of analysis in stroke patients with various degrees 
of disability is still lacking.  
The aims of this study were twofold: to investigate test-retest reliability and repeatability of 
CPET on the RATT in stroke patients with all degrees of disability; and to prospectively study 
changes in cardiopulmonary outcomes in this sample over a period of four weeks. 
 
2. Methods 
 
Study design and participants 
This prospective study was approved by the Ethics Review Committee of Canton Aargau, 
Switzerland (Ref. EKNZ 2014-296). All subjects gave their written informed consent before 
participating in the study.  
Sub-acute and chronic stroke patients were recruited from Reha Rheinfelden, a 
rehabilitation centre in the north-west of Switzerland, from December 2014 to January 2016. 
Patient inclusion criteria were: (1) a diagnosis of first-ever stroke, either ischaemic or 
intracerebral haemorrhagic; (2) ≥ 18 years old; and (3) willing to cooperate in the study and 
able to attend all testing sessions. Exclusion criteria were: (1) any contraindications to 
maximal exercise testing according to the American College of Sports Medicine guidelines 
(Pescatello et al., 2014); (2) any contraindications for the RATT based on guidelines from the 
manufacturer; (3) severe perceptual or communication problems; (4) Mini Mental State 
Examination (MMSE) score ≤ 17 (Folstein et al., 1975); (5) concurrent neurological diseases, 
e.g. Parkinson’s disease; and (6) severe concurrent cardiac or pulmonary disease. A 
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cardiologist evaluated the cardiac status of all patients before giving approval for 
participation. 
Patients’ characteristics were recorded prior to the first test: gender, age, height, body mass, 
body mass index (BMI), type of stroke, time of stroke diagnosis, side of weakness, 
comorbidity and current medication. 
Study protocol 
Patients underwent 3 separate CPET sessions: 2 tests at baseline (TB1 and TB2) and 1 test at 
follow up (TF). TB2 was conducted as soon as possible after TB1, but at least 24 hours later. 
TB2 and TF were 4 weeks apart. Patients were instructed to avoid strenuous activity within 
the 24 hours before each test session, not to consume a large meal 3 hours before, and to 
refrain from caffeine and nicotine 12 hours prior to testing. 
Functional assessment 
Prior to cardiopulmonary exercise testing, functional measures were assessed using 
functional ambulation category (FAC) (Holden et al., 1984), the National Institutes of Health 
Stroke Scale (NIHSS) (Brott et al., 1989) and a 6-minute walk test (6 MWT). The 6 MWT was 
performed indoors along a straight 50 m walking course. Standardized instructions were 
given to the patients according to the guidelines (ATS Committee, 2002). The six-minute 
walk distance (6MWD) was recorded. 
Cardiopulmonary fitness assessment 
Cardiopulmonary exercise testing (CPET) was performed using a robotics-assisted tilt table 
(RATT; model Erigo, Hocoma AG, Switzerland; Figure 1). Each test session had the same 
format. The patient was first transferred and secured using the body harness, thigh cuffs and 
foot plates according to the instruction of the manufacturer. Then, the patient was tilted 
upwards to 70 degrees. During the passive and incremental exercise phases, the stepping 
cadence was set at 80 steps/min, which is the maximal cadence allowed by the device. 
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Figure 1. Robotics-assisted tilt table (RATT) with visual feedback system. The visual 
feedback screen shows the target work rate and the subject’s work rate. The latter was 
calculated from the forces in the thigh cuffs and the angular velocities.  Adapted from 
(Saengsuwan et al., 2015c).  
 
The CPET methodology was previously described in detail elsewhere (Saengsuwan et al., 
2015a) and it is briefly summarized in the following. CPET consisted of the following phases: 
(1) a 3-min rest phase, where the patient lay without leg movement on the RATT; (2) a 
passive phase, where the RATT moved the patient's legs for 5 min and the measured relative 
work rate was adjusted to 0 W; (3) a ramp phase, where the rate of work rate increase was 
in the range 1.25 to 4.5 W/min – the work rate ramp was estimated by patients’ gender, age, 
level of weakness and comorbidity, e.g. the ramp rate for a 70 year old woman with severe 
disability was set to 1.25 W/min – the aim of the individualised ramp rate was to bring the 
patient to their maximal effort within 8-12 min of ramp onset; and (4) a recovery phase, 
where the patient remained passive while the RATT moved their legs for 5 min. The 
termination criteria for the ramp phase followed the American College of Sports Medicine 
guidelines (Pescatello et al., 2014). Additionally, blood pressure (BP) was used as a 
termination criterion: systolic BP > 210 mmHg or diastolic BP > 115 mmHg (Tang et al., 
2006). 
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Metabolic gas exchange was recorded throughout using a breath-by-breath system 
(MetaMax 3B, Cortex Biophysik GmbH, Germany); the data were analysed using the 
associated Metasoft software. Prior to each test, standardized pressure, volume and 
precision gas calibration were performed according to the manufacturer's instructions. Heart 
rate was continuously recorded using a chest strap (model T34, Polar Electro Oy, Finland). 
Blood pressure was measured by manual sphygmomanometry every 2 min during the tests.  
Outcome measures 
The primary outcome measures were: 
1. Maximal outcomes: 
• Peak oxygen uptake, denoted V'O2peak. This was determined as the maximum of a 
15-breath average during the ramp phase. 
• Peak heart rate, HRpeak: the highest value of HR during the ramp phase. 
• Peak respiratory exchange ratio, RERpeak: the 15-breath average at the time of 
V'O2peak. 
• Peak work rate, WRpeak. This was calculated as the highest work rate achieved. 
2. Submaximal outcomes: 
• Oxygen uptake at the ventilatory anaerobic threshold VAT (V'O2VAT): the method 
for determination of VAT is summarized below. 
• Oxygen uptake at the respiratory compensation point RCP (V'O2RCP), described 
below. 
The secondary outcome measures were: 
• Rating of perceived exertion (RPE) for dyspnea and leg effort at the time of peak 
exercise (Borg CR10) (Borg, 1990).  
• Heart rate at the VAT (HRVAT) and heart rate at the RCP (HRRCP). 
• Six-minute walk distance (6 MWD). 
• The value of V'E/V'O2 at VAT and V'E/V'CO2 at RCP, and the slope of minute 
ventilation versus carbon dioxide output (V'E-vs-V'CO2) from the start of the ramp 
phase to the RCP. 
The ventilatory anaerobic threshold (VAT) and the respiratory compensation point (RCP) 
were determined as the averages from two independent raters (JS and LB) providing that the 
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difference in the V'O2 values of the corresponding points between two raters was less than 
100 mL/min. In the case of any discrepancy, a third rater (KH) rated the point, and the VAT 
or RCP was the averaged data of the 2 closest values. The methods used to determine the 
VAT and RCP were those described by Binder et al. (2008) and summarised in the following. 
The VAT was determined using the combination of these criteria: (1) the point where the 
ventilatory equivalent of oxygen (V'E/V'O2) reaches its minimum or starts to increase 
without an increase in the ventilatory equivalent of carbon dioxide (V'E/V'CO2); (2) the point 
at which the partial pressure of end-tidal oxygen tension (PETO2) reaches a minimum or 
starts to increase without a decline in the partial pressure of end-tidal carbon dioxide 
tension (PETCO2); and, (3) the point of deflection of V'CO2 versus V'O2 (V-slope method). The 
first two criteria were prioritized in the case that the 3 criteria gave different results. 
The RCP was determined by: (1) the minimal value or nonlinear rise of V'E/V'CO2; (2) the 
point that PETCO2 starts to decline; and, (3) the point of deflection of V'E versus V'CO2. Again, 
the first two criteria were prioritized. 
Statistical analysis 
Continuous variables are presented as mean ± standard deviation (SD). Categorical variables 
are presented as frequencies and percentages. Test-retest reliability of submaximal 
parameters on each device was analysed using an intraclass correlation coefficient (ICC3,1) 
(Weir, 2005). For the interpretation of results, 0.40 ≤ ICC < 0.75 was considered as fair to 
good reliability and ICC ≥ 0.75 was considered excellent reliability (Rosner, 2010). The within-
subject coefficients of variation (CoV) were calculated (Bland and Altman, 1996).  
Repeatability was analysed using the Bland and Altman limits of agreement (LoA). 
Heteroscedasticity was examined by calculating Pearson’s correlation coefficient (r) between 
the absolute difference and the corresponding means. When r>0.1 was found, the data were 
considered heteroscedastic. The heteroscedastic data were log transformed using base 10 
and r was recalculated. If r decreased, the data were analysed using log-transformation. The 
limits of agreement for heteroscedastic data were transformed back and displayed in the 
Bland Altman plots as a linear function ± bx̄ calculated by the method described by Euser et 
al. (2008), where x̄ is the data mean and b is the slope of the LoA. If the data were 
homoscedastic, or the data were heteroscedastic but the log-transformed data did not 
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reduce the correlation coefficient, the limits of agreement were reported as the standard 
mean difference (MD) ± 1.96 SD of the difference (Bland and Altman, 1986). 
Two-sided paired t-tests were used to test differences between TB1 and TB2, as well as 
between TB2 and TF, if the difference between the tests was normally distributed (Shapiro 
Wilk test). Otherwise, the Wilcoxon-signed rank test was used. The significance level was set 
at 0.05. The analyses were performed using SPSS (Version 20.0, IBM Corp., Armonk, NY) 
 
3. Results 
 
General observations 
Seventeen patients (9 females) aged 62.7 ± 10.4 years (mean ± SD) completed the test 
sessions (Table 1). Four patients were wheelchair bound, 12 patients were mildly affected 
and could walk independently, and one patient could walk with assistance. A further three 
patients were recruited but did not complete the study because of, respectively, severe 
hypertension, new onset atrial fibrillation, or due to automatic shutdown of the RATT caused 
by inappropriate forces. 
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Table 1. Characteristics and demographic data of subjects (n=17). 
Characteristic Value Range 
Age (years)  62.7 (10.4) 41.0-78.0 
Sex, n (%) 
Male 
Female  
 
9 (52.9%) 
8 (47.1%) 
 
Height (cm) 169.5±6.6 160.0-183.0 
Body mass (kg) 72.3±10.0 57.5-90.0 
Body mass index (kg/m2) 25.2±3.2 20.2-33.1 
Type of stroke, n (%) 
Ischaemic 
Haemorrhagic 
 
15 (88.2%) 
2 (11.8%) 
 
Hemiparetic side, n (%)  
Left 
Right 
 
7 (41.2%) 
10 (58.8%) 
 
Stage, n (%) 
Sub-acute 
Chronic 
 
6 (35.3%) 
11 (64.7%) 
 
Days post stroke, median (IQR) 350 (788) 21-1810 
FAC 3.6±2.1 0-5 
NIHSS 3.1±3.2 0-11 
MMSE score 28.1±2.3 21-30 
Comorbidities, n (%)  
Hypertension  
Diabetes mellitus 
Dyslipidemia 
None 
 
9 (52.9%) 
1 (5.9%) 
4 (23.5%) 
4 (23.5%) 
 
Antihypertensive Medications, n (%) 
β-blocker 
ACE inhibitors  
Calcium channel blockers 
None 
 
2 (11.9%) 
3 (17.6%) 
3 (17.6%) 
9 (52.9%) 
 
Values are mean±SD unless otherwise indicated. 
Abbreviations: n, number; SD, standard deviation; MMSE, Mini Mental State Examination; 
IQR, Interquartile range; FAC, Functional Ambulation Category; ACE, angiotensin-converting-
enzyme. 
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There were no complications or serious adverse events. The ramp-phase duration was 8 min 
53 sec ± 2 min 17 sec. Of the total of 51 completed exercise test sessions (17 patients x 3 
sessions each), 49 sessions were terminated at the patient’s own volition (functional 
capacity reached). The most common reasons for volitional exercise termination were leg 
fatigue (45.1%), generalized fatigue (17.6%) and inability to maintain the target work rate 
(15.7%). One further session was terminated because blood pressure reached the upper 
limit (SBP > 210 mmHg) and 1 session because of the feeling of pain from a pre-existing 
tension headache.  
Overall, the VAT and RCP were identifiable in 49 of 51 tests (96.1%) and 40 of 51 tests 
(78.4%), respectively: this allowed 16 paired comparisons of V'O2VAT to be done for TB1 vs 
TB2 (test-retest) and for TB2 vs TF (four-week changes); 12 paired comparisons of V'O2RCP 
were able to be done for TB1 vs TB2 and 11 comparisons for TB2 vs TF (Tables 2 and 3). 
There was one measurement problem for submaximal heart rate recording in TB1, so the 
pairwise comparison for HRVAT and HRRCP were 1 pair lower than for the submaximal V'O2 
pairs (test-retest). 
Test-retest reliability (TB1 vs TB2) 
The first and second baseline tests (TB1 and TB2) were 2.1 ± 2.1 days apart. The primary 
outcomes (V'O2peak, HRpeak, RERpeak, WRpeak, V'O2VAT and V'O2RCP) showed good to excellent 
test-retest reliability with ICCs in the range of 0.65 to 0.94. Overall, peak exercise 
performance parameters showed higher reliability compared to submaximal exercise 
parameters: V'O2peak had a better reliability and repeatability shown by a higher ICC, a lower 
or equal coefficient of variation and a smaller mean difference (ICC 0.85, CoV 11.6%, MD 
25.8 mL/min) compared to V'O2VAT (ICC 0.67, CoV 14.5%, MD 60.1 mL/min) and V'O2RCP (ICC 
0.65, CoV 11.6%, MD 46.3 mL/min). Most cardiopulmonary exercise parameters were 
slightly higher in TB2:  a statistically significant difference was found between the tests only 
for V'O2VAT (575.4 mL/min in TB1 vs 635.5 mL/min in TB2, p = 0.045). For the Bland and 
Altman analysis, the variables V'O2peak, V'O2VAT and HRVAT as a percentage of HR reserve were 
found to be heteroscedastic and the limits of agreements were calculated from the log-
transformed data (Table 2, Figure 2). 
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Amongst the secondary outcomes, HRVAT, HRRCP, V'E/V'O2 at VAT, V'E/V'CO2 at RCP, V'E-vs-
V'CO2 slope and the six-minute walk distance (6 MWD) showed excellent reliability with ICC 
from 0.76 to 0.95 and CoV less than 6%. The only significant difference between TB1 and TB2 
was for the six-minute walk test (MD 25.8 m, p=0.01). The least reliable parameters as 
classified by the highest CoV (28.4 and 29.5%) were the patients’ subjective rating of 
perceived exertion (RPE), both for leg effort and dyspnea.  
Changes in cardiopulmonary fitness after 4 weeks (TB2 vs TF) 
The follow up test (TF) was 30.4 ± 10.2 days after the second baseline measurement (TB2). 
No significant changes were found in V'O2peak, HRpeak, RERpeak, WRpeak, or V'O2RCP (Table 3), 
but V'O2VAT showed a statistically significant decrease (637.4 mL/min in TB2 vs 569.3 mL/min 
in TF, p=0.002). Regarding secondary outcomes, mean RPE for leg effort in TF was lower than 
for TB2 but the other variables were comparable (Table 3). 
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Table 2. Test-retest reliability of the cardiopulmonary performance parameters (n=17), unless otherwise indicated. 
 TB1  
(mean ± SD) 
 TB2 
(mean ± SD) 
p-value MD  
 
95%CI  SDD 95% LoA CoV 
(%) 
ICC (95% CI) 
Absolute V'O2peak (mL/min)  1130.5±349.4 1156.4±376.6 0.60 25.8 -77.4, 129.1  200.8 -0.26x,̄ 0.26x ̄ 11.6 0.85 (0.64, 0.94 ) 
Relative V'O2peak (mL/kg/min) 15.7±4.7 16.0±4.9 0.65 0.3 -1.1, 1.7 2.8 -0.26x,̄ 0.26x ̄ 11.6 0.84 (0.61, 0.94) 
HRpeak (beats/min) 120.9±26.3 124.2±25.2 0.26 3.2 -2.6, 9.0 11.3 -18.9, 25.3 6.9 0.90 (0.76, 0.96) 
HRpeak% of APMHR 78.0±15.0 80.1±13.6 0.26 2.04 -1.6, 5.7  7.2 -12.1, 16.2 6.9 0.87 (0.69, 0.95) 
RERpeak 1.06±0.09 1.08±0.08 0.10 0.02 -0.01, 0.52  0.06 -0.1, 0.1 4.1 0.78 (0.49, 0.91) 
WRpeak (W)  28.0±12.4 29.0±13.3 0.36 1.07 1.4, 3.5  4.6 -7.9, 10.1 13.4 0.94 (0.83, 0.98) 
Absolute V'O2VAT (mL/min) 
(n=16) 575.4±105.9 635.5±177.3 0.045 60.1 
 
-1.4, 118.9  110.2 -0.34x,̄ 0.34x ̄ 14.5 0.67(0.27 , 0.87) 
Relative V'O2VAT (mL/kg/min) 8.0±1.6 8.8±2.4 0.050 0.8 0.0, 1.6 1.5 -0.34x,̄ 0.34x ̄ 14.5 0.68 (0.29, 0.88) 
V'O2VAT% of V'O2peak (%) 50.3±9.4 53.1±9.1 0.27 2.8 -2.4, 8.2 10 -16.8, 22.4 15.4 0.41 (-0.07, 0.74) 
HRVAT (beats/min) (n=15) 89.5±9.3 91.9±9.7 0.17 2.4 -1.1, 6.0 6.5 -10.3, 15.1 5.5 0.76 ( 0.44, 0.91) 
HRVAT % of HR reserve 32.6±9.2 35.1±11.5 0.33 2.5 -2.8, 7.8 9.5 -16.1, 21.1 19.5 0.58 (0.13, 0.84) 
HRVAT % of APMHR 57.3±5.4 58.8±5.2 0.20 1.5 -0.9, 3.8 4.3 -0.62x,̄ 0.62x ̄ 5.5 0.67 (0.28, 0.87) 
Absolute V'O2RCP (mL/min) 
(n=12) 956.5±197.9 1002.9±179.4 0.33 46.3 
 
-54.1, 146.6 157.9 
-263.2, 
355.8 11.6 0.65 (0.17, 0.88) 
Relative V'O2RCP (mL/kg/min) 13.4±2.5 14.1±2.5 0.28 0.7 -0.7, 2.1 2.1 -3.4, 4.8 11.6 0.77 (0.24, 0.87) 
V'O2RCP% of V'O2peak (%) 77.2±8.8 82.1±6.8 0.035 4.9 0.4, 9.5 7.1 -9.0, 18.8 8.3 0.50 (-0.02, 0.82) 
HRRCP (beats/min) (n=11) 112.5±18.2 113.6±17.7 0.42 1.1 -5.3, 7.4 9.4 -17.3, 19.5 5.8 0.87 (0.59, 0.96) 
HRRCP % of HR reserve 70.2±16.2 73.6±10.8 0.48 3.5 -7.0, 14.0 15.6 -27.1, 34.1 18.4 0.37 (-0.28, 0.78) 
HRRCP % of APMHR 71.3±12.1 71.9±11.7 0.72 0.7 -3.2, 4.6 5.8 -10.7, 12.1 5.8 0.89 ( 0.64, 0.97) 
RPE dyspnea 5.1±2.0 5.2±2.7 0.93 0.1 -0.8, 0.9 1.7 -3.2, 3.4 28.4 0.76 (0.44, 0.91) 
RPE leg effort 6.8±2.1 7.5±1.6 0.23 0.8 -0.3, 1.8 2 -3.1, 4.7 29.5 0.41 (-0.04, 0.73) 
V'E/V'O2 at VAT 31.8±4.8 32.8±5.0 0.28 0.9 -0.8, 2.7 3.3 -5.6, 7.4 7.3 0.77 (0.48, 0.91) 
V'E/V'CO2 at RCP 33.8±3.7 33.8±3.7 0.91 0.1 -1.2, 1.3 2.0 -3.9, 4.0 4.5 0.87 (0.60, 0.96) 
V'E-vs-V'CO2 slope to RCP 32.2±4.8 33.0±5.5 0.36 0.8 -1.0, 2.6 2.8 -4.7, 6.3 6.1 0.85 (0.58,0.96) 
6 MWD (n=12) 502.5±113.4 528.3±113.1 0.010 25.8 7.5, 44.1 28.7 -30.5, 82.1 5.6 0.95 (0.65, 0.99) 
TB1 = baseline test 1, TB2 = baseline test 2, APMHR = age-predicted maximal heart rate, VAT = ventilatory anaerobic threshold, RCP = respiratory 
compensation point, 6 MWD = 6 minute-walk distance, MD = mean difference, SDD = standard deviation of difference, LoA = limits of agreement, 
CoV = coefficient of variation, ICC = intraclass correlation coefficient, CI = confidence interval, x ̄= individual average. 
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Figure 2. Bland-Altman plots for the main outcome measures. The differences between test 2 (TB2) and test 1 (TB1) are plotted against the 
average values of TB1 and TB2. 
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Table 3. Changes in cardiopulmonary fitness during 4 weeks (n=17), unless otherwise indicated. 
 Baseline test 2 (TB2) 4-week follow up 
(TF) 
MD (95%CI) (TF-TB2) p-value  % changes 
(95%CI) 
Absolute V'O2peak 
(mL/min) 
1156.4±376.6 1170.0±397.5 13.6 (-102.9, 130.2) 0.81 2.8 (-6.3, 11.9) 
Relative V'O2peak 
(mL/kg/min) 
16.0±4.9 16.2±5.0 0.2 (-1.3, 1.6) 0.80 2.8 (-6.3, 11.9) 
HRpeak (beats/min) 124.2±25.2 124.5±23.5 0.4 (-4.7, 5.4) 0.88 0.9 (-3.1, 5.0) 
RERpeak 1.08±0.08 1.08±0.10 0.001 (-0.02, 0.03) 0.89  0.2 (-2.3, 2.6) 
WRpeak (W) (n=16) 29.0±13.3 30.0±14.0 1.0 (-1.8, 3.8) 0.46 2.6 (-7.3, 12.6) 
Absolute V'O2VAT 
(mL/min) (n=16) 
637.4±173.3 569.3±151.3 -68.1 (-107.5, -28.7) 0.002 -9.6 (-15.1, 4.0) 
Relative V'O2VAT 
(mL/kg/min) 
8.8±2.3 7.9±2.0 -0.9 (-1.5, -0.4) 0.002 -9.6 (-15.1, 4.0) 
HRVAT (beats/min) 93.8±11.5 91.1±7.4 -2.6 (-6.8, 1.5) 0.20 -2.1 (-6.2, 2.0) 
Absolute V'O2RCP 
(mL/min) (n=11) 
1018.7±179.1 1055.4±199.4 36.7 (-80.4, 153.7) 0.50 4.5 (-5.9, 14.9) 
Relative V'O2RCP 
(mL/kg/min) 
14.2±2.5 14.7±2.5 0.5 (-1.0, 1.9) 0.48 4.5 (-5.9, 14.9) 
HRRCP (beats/min) 118.2±16.8 116.8±19.0 -1.3 (-8.8, 6.1) 0.69 -1.0 (-7.7, 5.7) 
RPE dyspnea 5.2±2.7 4.5±1.9 -0.7 (-1.9, 0.5) 0.25 -0.7 (-25.2, 23.8) 
RPE leg effort 7.5±1.6 6.1±2.2 -1.4 (-2.8, -0.2) 0.028 -16.4 (-32.4, 0.4) 
V'E/V'O2 at VAT 
(n=16) 
32.4±4.6  32.4±4.2 0.1 (-1.2, 1.3) 0.93 0.5 (-3.2, 4.3) 
V'E/V'CO2 at RCP 
(n=11) 
33.7±3.8 33.5±4.4 -0.1 (-1.7, 1.4) 0.86 -0.4 (-5.2, 4.5) 
V'E-vs-V'CO2 slope 
to RCP (n=11) 
32.8±5.7 32.0±4.6 -0.8 (-3.4, 1.9) 0.53 -1.3 (-8.4, 5.8) 
6MWD (n=12) 528.3±113.1 526.7±114.5 -1.7 (-26.1 to 22.8) 0.89 0.1 (-5.0 to 5.2) 
MD = mean difference, CI = confidence interval. 
 
4. Discussion 
  
This study had two aims: to investigate test-retest reliability and repeatability of CPET on the 
RATT in stroke patients with all degrees of disability; and to prospectively study changes in 
cardiopulmonary outcomes in this sample over a period of four weeks. 
 
Test-retest reliability 
Good to excellent reliability was found in V'O2peak, HRpeak, RERpeak, WRpeak, V'O2VAT and 
V'O2RCP. Overall, there were slightly higher cardiopulmonary performance parameter values 
in test 2, but only the difference in V'O2VAT reached statistical significance.  
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The test-retest reliability of the peak cardiopulmonary exercise parameters observed here in 
stroke patients was lower than values seen previously in normal subjects exercising on the 
RATT: e.g., V'O2peak in normal subjects had an ICC of 0.97 and CoV 4.1%  compared to ICC of 
0.85 and CoV of 11.6% found in this study (Saengsuwan et al., 2015b).  
Comparing the test-retest reliability results with other devices used in stroke patients is 
difficult as ICCs are often reported by different ICC methods. Additionally, test-retest 
reliability as calculated by other measures such as CoV are scarce in the stroke literature. 
Results from various previous studies found that V'O2peak obtained from a cycle ergometer, a 
semi-recumbent cycle ergometer, a treadmill and a robotics-assisted treadmill in both sub-
acute and chronic stroke yielded excellent reliability with ICC ranging from 0.82 to 0.98 
(Potempa et al., 1995;Dobrovolny et al., 2003;Duncan et al., 2003;Eng et al., 2004;Yates et 
al., 2004;Olivier et al., 2013;Stoller et al., 2014b). However, one study in sub-acute stroke 
patients using a semi-recumbent cycle ergometer showed poor reliability: there was an 
increase of 10% in V'O2peak in the second test and an ICC for V'O2peak of 0.50 (Tang et al., 
2006); the reason for this discrepancy is unclear.  
Additional maximal exercise parameters showed good to excellent test-retest reliability in 
previous reports. The ICC of 0.90 for HRpeak in the present study is comparable to previous 
reports (0.74 to 0.97) (Potempa et al., 1995;Dobrovolny et al., 2003;Duncan et al., 
2003;Yates et al., 2004;Tang et al., 2006;Olivier et al., 2013;Stoller et al., 2014b). Similarly, 
ICCs for RERpeak and WRpeak of 0.78 and 0.94 found here are in line with other reports (0.72 
for RERpeak and 0.99 for work rate) (Potempa et al., 1995;Dobrovolny et al., 2003). 
For the Bland and Altman analysis, we found that V'O2peak, V'O2VAT and HRVAT as a percentage 
of HR reserve were heteroscedastic. The finding of heteroscedasticity in V'O2peak was also 
previously reported in stroke patients and patients with cardiac or pulmonary problems 
(Bensimhon et al., 2008;Ovando et al., 2011;Stoller et al., 2014b). This means that patients 
with low V'O2peak have lower variation in the absolute test-retest difference compared to 
patients with higher V'O2peak. This finding is important as it implies that, for future studies, it 
would be necessary to plan the test-retest reliability protocol for specific levels of exercise 
capacity (i.e. V'O2peak) to get the most accurate results because variations in the test-retest 
data are not uniform. 
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For submaximal exercise thresholds, the reliability of V'O2VAT and V'O2RCP were lower than for 
V'O2peak: ICC was 0.67 and CoV was 14.5% for V'O2VAT; ICC was 0.65 and CoV was 11.6% for 
V'O2RCP. These values, again, reflect lower reliability compared to normal subjects on the 
same device: the ICC was 0.92 for both V'O2VAT and V'O2RCP and the CoV was 5.9% and 6.5% 
for V'O2VAT and V'O2RCP, respectively, for normals (Saengsuwan et al., 2015c). The finding of 
lower reliability for V'O2VAT and V'O2RCP compared to V'O2peak was not unexpected as this was 
previously documented in normal subjects, and in heart and lung patients (Barron et al., 
2014;Saengsuwan et al., 2015b;c). This was thought to be because of day-to-day biological 
variability, which may be related to intrinsic factors such as daily haemodynamic fluctuations 
(Bensimhon et al., 2008). Additionally, the lower reliability may be caused by intra and inter-
rater variability for the determination of the submaximal exercise thresholds. 
HRVAT and HRRCP were shown to have excellent reliability. These results suggest that the use 
of HRVAT and HRRCP to set the recommended intensity for exercise training could be 
implemented in practice. RPE showed the lowest reliability and repeatability. The findings in 
this respect support previous evidence that RPE is not an appropriate indicator of exercise 
intensity in stroke patients at a high-intensity exercise level (Sage et al., 2013). V'E/V'O2 at 
VAT, V'E/V'CO2 at RCP, and the V'E-vs-V'CO2 slope showed excellent test-retest reliability 
with CoVs comparable to normal subjects (CoV of 4.5 to 7.3% in stroke patients vs CoV of 2.5 
to 6% in normal subjects) (Saengsuwan et al., 2015c).  
In summary, based on this evidence, reliability and repeatability of the main CPET 
parameters obtained from the RATT are comparable to previous findings reported in stroke 
patients using standard exercise testing devices. However, the reliability and repeatability 
levels found here in stroke patients were generally lower than for normal subjects on the 
RATT. The lower reliability may be explained by the higher variation in day-to-day levels of 
motivation, levels of fatigue or impaired motor control in stroke patients.  
Changes in cardiopulmonary fitness after 4 weeks 
Apart from V'O2VAT, the main cardiopulmonary performance parameters did not 
demonstrate any statistically significant differences over the four week period. This may be 
because the follow up time was too short and because more than half of the patients who 
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participated in this study were in the chronic phase following stroke. The non-significant 
change in mean V'O2peak from 16.0 to 16.2 mL/kg/min is comparable to a study in a control 
group of chronic stroke patients: 15.1 to 15.2 mL/kg/min in a 10-week period (Potempa et 
al., 1995). This reflects that without any specific exercise intervention, changes in V'O2peak 
are unlikely to be seen over a short period. 
There was a significant difference (decrease) in V'O2VAT over the 4-week period (TB2 vs TF). 
However, based on the large and significant difference in V'O2VAT between tests TB1 and TB2 
(mean difference of +60.1 mL/min) and the fact that V'O2VAT from TB1 was only 575.4 
mL/min (Table 2), this is considered not clinically significant. 
General comments 
V'O2peak averaged over the three tests was 16 mL/kg/min. This is in line with previous reports 
and shows that cardiopulmonary fitness in stroke patients is low (8 to 22 mL/kg/min, 26 to 
87% of age and sex-matched prediction) (Smith et al., 2012). This overall mean V'O2peak is 
57.1% ± 14.2% of age and sex- matched predictions for a cycle ergometer (Fairbarn et al., 
1994). Therefore, this comparison needs to be interpreted with caution as V'O2peak and V'O2 
at submaximal exercise thresholds are device specific: it was found that peak and 
submaximal V'O2 were approximately 20% lower on the RATT than the cycle ergometer in 
normal subjects (Saengsuwan et al., 2015b;c). The low V'O2peak may be because of more 
body support provided and a difference in the movement pattern of exercise on the RATT 
(Saengsuwan et al., 2015b). The HR response is also device specific: the HRpeak of 80% of age 
predicted maximal heart rate (APMHR) obtained from CPET on the RATT in this study is at 
the lower end of the range for HRpeak reported for a recumbent cycle ergometer, an upright 
cycle ergometer and a treadmill in chronic ambulatory stroke patients (78.2 to 94.7% of 
APMHR) (Eng et al., 2004;Ovando et al., 2011;Marzolini et al., 2012).  
An RERpeak of > 1.0 is a recommended criterion for maximal effort in stroke patients (van de 
Port et al., 2015). This criterion was satisfied here in 82.4% of all tests, although severely 
disabled patients were included. This is considered a high proportion compared to previous 
reports of only 17.6 to 62.1 % in patients with sub-acute or chronic ambulatory stroke tested 
on a treadmill (MacKay-Lyons and Makrides, 2002;Kelly et al., 2003;Ovando et al., 2011), 
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44% of sub-acute stroke patients tested on a semi-recumbent cycle ergometer (Tang et al., 
2006), and 78.9% of sub-acute stroke patients using a cycle ergometer (Chen et al., 2010). 
These differences in the proportion of patients who achieved the criterion for maximal effort 
points to the importance of the device employed for CPET. Patients may experience difficulty 
exercising at high treadmill speed because of balance problems or fear of falling and they 
may have problems with leg control during cycling that prevents them from reaching their 
maximal exercise capacity. The RATT, in contrast, provides a body harness, thigh cuffs and 
foot plates to secure the patients, thus enabling them to exercise to a higher intensity.  
Overall, the VAT was identified in 16/17 (94.1%) (TB1), 17/17 (100%) (TB2) and 16/17 
(94.7%) (TF) patients. The RCP was identified in 13/17 (76.5%) (TB1), 14/17 (82.4%) (TB2) 
and 13/17 (76.5%) (TF) patients. The VAT was previously demonstrated to be identifiable in 
67.3 to 83.5% of chronic stroke patients exercising on a semi-recumbent cycle ergometer, an 
upright cycle ergometer or a treadmill (Marzolini et al., 2012). To the best of our knowledge, 
there are no other studies in stroke patients that reported identification of an RCP, which is 
a point of substantially higher exercise intensity than the VAT, apart from our own feasibility 
study (Saengsuwan et al., 2015a). The finding of high proportions of patients who exercised 
to a sufficiently high level of intensity to allow identification of both the VAT and the RCP 
could be beneficial for the prescription of individualised exercise programmes (Mezzani et 
al., 2013). 
HRVAT in this study was lower than the value reported  in mild to moderate chronic stroke on 
a treadmill: here, HRVAT was approximately 59% of APMHR and in a study of Bosch et al. 
(2015) (n=8) it was 66% of APMHR. This difference may be due to the device specific 
responses to exercise as mentioned above. 
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Limitations 
The strict patient eligibility criteria described in Methods and the exclusion of patients who 
had cardiac problems or who were not approved by the cardiologist for CPET led to the small 
sample size in this study, which may limit generalizability of the findings.  
 
5. Conclusions 
 
These findings provide the first evidence of test-retest reliability and repeatability of the 
principal CPET variables using the novel RATT system and testing methodology. Good to 
excellent test-retest reliability and repeatability were found for all submaximal and maximal 
CPET variables. Reliability and repeatability of the main CPET parameters in stroke patients 
on the RATT were comparable to previous findings in stroke patients using standard exercise 
testing devices. There were no significant changes in most cardiopulmonary exercise testing 
outcomes over a period of four weeks. 
 
Abbreviations 
APMHR: age-predicted maximal heart rate; CoV: coefficient of variation; CPET: 
cardiopulmonary exercise testing; HR: heart rate; HRpeak: peak heart rate; ICC: intraclass 
correlation coefficient; LoA: limits of agreement; MD: mean difference; PETCO2: partial 
pressure of end-tidal carbon dioxide tension; PETO2:  partial pressure of end-tidal oxygen 
tension; RATT: robotics-assisted tilt table; RCP: respiratory compensation point; RERpeak: 
peak respiratory exchange ratio; RPE, rating of perceived exertion; V'CO2: carbon dioxide 
output; V'E: minute ventilation; V'E/V'CO2: ventilatory equivalent of carbon dioxide; 
V'E/V'O2: ventilatory equivalent of oxygen; V'O2: oxygen uptake; V'O2peak: peak oxygen 
uptake; VAT: ventilatory anaerobic threshold; WRpeak: peak work rate; 6 MWD: six-minute 
walk distance. 
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4. General Discussion and Outlook 
 
4.1 Recap of motivation and aim 
Maximal or peak oxygen uptake (V'O2max or V'O2peak) obtained from cardiopulmonary 
exercise testing (CPET) on a cycle ergometer or a treadmill is the gold standard measure for 
determining cardiopulmonary fitness (Pescatello et al., 2014). However, testing using a cycle 
ergometer or a treadmill is possible only in stroke patients with mild to moderate disability. 
In patients with severe disability after neurological insult, there are limited data regarding 
their cardiopulmonary fitness. Exercise testing and training in severely disabled patients is 
understudied (Smith et al., 2012;Stoller et al., 2012), which may be due mainly to the 
limitation of current devices to be used for these patients. Therefore, the aim of this PhD 
research was to investigate the clinical feasibility of using the augmented RATT as a method 
for cardiopulmonary exercise testing and training in stroke patients. The main findings of this 
research are summarized below. 
 
4.2 Principal findings of this thesis 
4.2.1 Cardiopulmonary performance testing using a robotics-assisted tilt 
table: feasibility assessment in able-bodied subjects 
 
The first phase of the study aimed to conduct a feasibility study using the RATT for 
cardiopulmonary exercise testing in healthy able-bodied subjects (Chapter 3.1). For this 
purpose, the RATT was augmented with force sensors, a work rate calculation algorithm and 
a visual feedback system. The approach was found to be technically implementable and 
substantial cardiopulmonary responses were observed. The V'O2peak obtained was 20% lower 
than the predicted V'O2peak on the cycle ergometer (Wasserman et al., 1999).  The lower 
V'O2peak observed may be explained by a lower level of muscle-mass recruitment during 
exercise on the RATT compared to standard exercise testing devices because of the body 
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support provided and the limited range of movement available on the RATT (Saengsuwan et 
al., 2014). 
 
4.2.2 Comparison of peak and submaximal cardiopulmonary performance 
parameters on a robotics-assisted tilt table, a cycle and a treadmill 
The second phase of the study (Chapters 3.2 and 3.3) compared the peak and submaximal 
cardiopulmonary performance parameters achieved from the RATT, a cycle ergometer and a 
treadmill. Test-retest reliability of the parameters was also established. V'O2peak, V'O2VAT and 
V'O2RCP on the RATT were   ̴20% lower than for the cycle ergometer and   3̴0% lower than on 
the treadmill. A very high correlation was found between the RATT vs the cycle ergometer 
V'O2peak (r=0.95, p<0.001) and the RATT vs the treadmill V'O2peak (r=0.94, p<0.001). High 
correlations for V'O2VAT and V'O2RCP were found between the RATT vs the cycle ergometer 
and the RATT vs the treadmill (r on the range 0.69 to 0.80). Additionally, test-retest reliability 
of the V'O2peak, V'O2VAT and V'O2RCP obtained from the RATT was similarly high as with the 
standard exercise devices. These findings suggest that the RATT is a valid and reliable device 
for CPET. Therefore, the RATT may have potential to be used in severely impaired patients 
who cannot use the standard modalities (Saengsuwan et al., 2015b;c).  
 
4.2.3 Feasibility of cardiopulmonary exercise testing and training using a 
robotics-assisted tilt table in dependent-ambulatory stroke patients 
The next phase of the study (chapter 3.4) evaluated the feasibility of the RATT for CPET and 
exercise training in dependent-ambulatory stroke patients, i.e. those with severe physical 
disability who are unable to use standard devices. The RATT could successfully be used for 
both CPET and exercise training in stroke patients without the need to further modify the 
system. The patients could understand the task to keep up with the work rate target on the 
visual feedback screen by adapting their volitional leg effort. All patients could exercise until 
the end of the protocols without any complications. Absolute V'O2peak was 845 ± 266 mL/min 
(relative V'O2peak was 11.9 ± 4.0 mL/kg/min), which corresponds to 45.2% of the expected 
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V'O2max based on the prediction method of Wasserman et al. (1999). For exercise training, all 
patients were able to sustain exercise at the recommended intensity level based on a 
percentage of V'O2 reserve, percentage of HRmax, and rate of perceived exertion (RPE) for 10 
min (Billinger et al., 2014). In summary, the RATT was found to be technically 
implementable, it was well tolerated by the patients, and substantial cardiopulmonary 
responses were observed (Saengsuwan et al., 2015a). This is the first evidence to prove that 
the RATT can be used for CPET and exercise training in severely disabled stroke patients. 
 
4.2.4 Test-retest reliability and four-week changes in cardiopulmonary fitness 
in stroke patients: evaluation using a robotics-assisted tilt table 
Test-retest reliability of peak and submaximal cardiopulmonary exercise parameters, which 
are normally used as the main outcomes for exercise intervention studies, would be relevant 
for the future implementation of this device. As these data are lacking in stroke patients, the 
final phase of this project focused on analysing test-retest reliability and investigating 
changes in cardiopulmonary fitness during 4 weeks (Chapter 3.5). Good to excellent test-
retest reliability (ICC 0.65-0.94, CoV 4.1-14.5%) and repeatability (mean differences close to 
zero) were found for most submaximal and maximal CPET variables. Overall, test-retest 
reliability results were comparable to standard exercise devices used for CPET in stroke 
patients. There were no significant differences in most CPET parameters over the period of 
four weeks.  
In summary, the RATT is an appropriate alternative exercise testing device in patients who 
have limitations with standard modalities. Test-retest reliability of CPET variables was found 
to be comparable to standard exercise testing devices. 
 
4.3 Clinical implications 
Although CPET is recommended to be done in stroke patients in order to determine their 
physical fitness and to prescribe individualised exercise programmes, the implementation of 
CPET is still limited (Billinger et al., 2014). One of the limitations is the lack of appropriate 
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exercise testing devices that can be used in patients with disability (Tang et al., 2009a). To 
the best of our knowledge, this is the first study that implemented the RATT for CPET and 
exercise training in stroke patients. This project provided scientific data regarding validity 
and reliability of CPET in both normal subjects and in stroke patients. The implementation of 
the RATT for CPET, on the one hand, widens the range of eligible patients as severely 
disabled patients can also be tested. On the other hand, it widens the application of the 
RATT beyond early neurorehabilitation. Additionally, the fact that severely disabled stroke 
patients were able to exercise on the RATT and achieved the recommended exercise 
intensity provides an important basis for planning exercise interventions. Currently, there 
are few studies which specifically focus on this aspect (Chang et al., 2012;Stoller et al., 2015). 
Exercise training in this group of patients to improve their cardiopulmonary fitness would 
have a positive impact on their daily activities and would lessen the risk of other diseases 
related to deconditioning, e.g. coronary artery disease (Powell et al., 1987). Numerous 
studies showed that higher cardiopulmonary fitness is linked with the ability to live 
independently (Morey et al., 1998;Paterson et al., 1999), a lower risk of all-cause mortality 
(Blair et al., 1996;Mora et al., 2003;Sawada et al., 2014) and lower incidence of chronic 
diseases such as dyslipidemia, cancer or depression (Becofsky et al., 2015;Lakoski et al., 
2015;Park et al., 2015). 
 
4.4 Limitations  
Although the answer to the main aim of this research was positive, there were some 
unavoidable limitations in the study. First of all, it cannot be verified whether the observed 
differences in peak and submaximal exercise parameters on each device (the RATT, the cycle 
ergometer and the treadmill) would be the same for severely disabled neurological patients 
because it is not possible to carry out the exercise tests on standard devices (e.g. treadmill) 
in severely disabled patients. Secondly, although we tried to make the data more 
generalizable by including both sub-acute and chronic stroke patients as well as including 
patients with all degrees of disability, the patients who participated in our study did not 
necessarily represent stroke patients in the general population. The patients enrolled in the 
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study were younger (mean age of 62.7 years) than in other reports (mean age of 66.0-72.5 
years) (Michel et al., 2010;O'Donnell et al., 2010). Participants were screened and approved 
by a cardiologist for cardiac safety and, as a result, our sample may be healthier than stroke 
patients in general. Additionally, they may be more motivated than their non-participating 
peers. Thirdly, because of time limitations, we had a rather small sample size for test-retest 
reliability analysis. However, as most studies of test-retest reliability in stroke patients had 
sample sizes of 9 to 53 (Potempa et al., 1995;Dobrovolny et al., 2003;Duncan et al., 2003;Eng 
et al., 2004;Yates et al., 2004;Tang et al., 2006;Olivier et al., 2013;Stoller et al., 2014b), we 
consider the sample size used in this study to be realistic and to provide valid preliminary 
data. 
 
4.5 Future directions 
 
As the RATT is a novel device in the context of exercise testing and training, several open 
questions remain. In order to effectively implement the RATT for exercise testing, a method 
to predict the optimal work rate increment for each patient that will bring the patient to 
their maximal exercise capacity in the desired duration of 8-12 min should be developed 
(Buchfuhrer et al., 1983). Moreover, the optimal cadence for CPET should be examined. 
Although the cadence used in this project was 80 steps/min (the highest rate possible on the 
RATT), it is not known what would be the most appropriate cadence for exercise testing and 
training in this group of patients.  
 
For exercise training, the next logical approach is to evaluate the effect of an individualised 
exercise intervention in early sub-acute or chronic stroke patients who are severely disabled. 
Future research will also need to focus on the most appropriate methods to implement 
exercise training in stroke patients, e.g. continuous mild-moderate intensity training or 
interval training. 
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